{"content":"<li class=\"n-box-item date-title\" data-end=\"1536638399\" data-start=\"1536552000\" data-txt=\"Monday, December 23, 2019\">Monday, September 10, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3389221\" data-ts=\"1536618598\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARTX\" target=\"_blank\">ARTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389221-arotechplus-6_9-on-10_2m-army-simulation-work-order\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arotech +6.9% on $10.2M Army simulation work order</a></h4><ul>   <li>Arotech (NASDAQ:<a href='https://seekingalpha.com/symbol/ARTX' title='Arotech Corporation'>ARTX</a>) is <font color='green'>up 6.9%</font> after hours following news that its FAAC unit <a href=\"https://seekingalpha.com/pr/17265552-arotech-s-faac-incorporated-receives-10_2m-funding-extend-capabilities-u-s-army-s-virtual\" target=\"_blank\">won $10.2M in Army funding</a> for its Virtual Clearance Training Suite program.</li>    <li>FAAC is part of Arotech's Training and Simulation Division, which makes and markets high-tech multimedia and interactive digital simulations for military, law enforcement, security, municipal and private industry personnel.</li>    <li>The deal envisions three phases, each of which would provide a block upgrade of capabilities to fielded VCTS systems. The new funding is for phase 2 and comes in the form of exercised options through January 2021.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3389221\" data-linked=\"Arotech +6.9% on $10.2M Army simulation work order\" data-tweet=\"$ARTX - Arotech +6.9% on $10.2M Army simulation work order https://seekingalpha.com/news/3389221-arotechplus-6_9-on-10_2m-army-simulation-work-order?source=tweet\" data-url=\"https://seekingalpha.com/news/3389221-arotechplus-6_9-on-10_2m-army-simulation-work-order\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389217\" data-ts=\"1536617409\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SONO\" target=\"_blank\">SONO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389217-sonosminus-14_5-first-public-earnings-show-in-line-revenues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sonos -14.5% as first public earnings show in-line revenues</a></h4><ul>   <li>Sonos (NASDAQ:<a href='https://seekingalpha.com/symbol/SONO' title='Sonos, Inc.'>SONO</a>) has <font color='red'>slipped 14.5%</font> after hours, more than erasing <font color='green'>gains of 13.3%</font> today after <a href=\"https://seekingalpha.com/news/3389168-sonos-beats-revenue\" target=\"_blank\">its first public earnings report</a> with largely in-line revenues seem to be disappointing investors that may have been hoping for a blowout.</li>    <li>Revenues fell 6.6% despite an 11.4% growth in units sold, which the company attributes to the year-ago launch of its Playbase product (its revenues fell by $18M Y/Y).</li>    <li>Gross margin fell 2.3 points Y/Y to 45.8% (it rose sequentially by 2.2 points).</li>    <li>Net loss widened to $26.99M largely due to the revenue drop.</li>    <li>Revenue by product: Wireless speakers, $93.9M (up 1.2%); Home theater speakers, $66.7M (down 20.5%); Components, $42.3M (down 4.3%); Other, $5.5M (up 152%).</li>    <li>For the full year, it's guiding to revenues of $1.109B-$1.114B and EBITDA of $59M-$62M.</li>    <li><a href=\"https://s22.q4cdn.com/672173472/files/doc_financials/2018/Q3/Sonos-Letter-to-Shareholders-3Q-FY2018.pdf\" target=\"_blank\">Shareholder letter</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3389217\" data-linked=\"Sonos -14.5% as first public earnings show in-line revenues\" data-tweet=\"$SONO - Sonos -14.5% as first public earnings show in-line revenues https://seekingalpha.com/news/3389217-sonosminus-14_5-first-public-earnings-show-in-line-revenues?source=tweet\" data-url=\"https://seekingalpha.com/news/3389217-sonosminus-14_5-first-public-earnings-show-in-line-revenues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389213\" data-ts=\"1536616031\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LMNR\" target=\"_blank\">LMNR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389213-limoneiraminus-16-profits-miss-amid-avocado-decline\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Limoneira -16% as profits miss amid avocado decline</a></h4><ul>   <li>Limoneira (NASDAQ:<a href='https://seekingalpha.com/symbol/LMNR' title='Limoneira'>LMNR</a>) has <font color='red'>tanked 16%</font> after a <a href=\"https://seekingalpha.com/news/3389162-limoneira-misses-0_05-beats-revenue\" target=\"_blank\">mixed Q3 report</a> where profits fell short of expectations, though revenues didn't decline as much as expected.</li>    <li>Excessive heat toward the end of the quarter also affected avocado quality, weighing on the company's sales expectations.</li>    <li>Revenues dipped 1.1% for the quarter, trimming YTD gains to 9%.</li>    <li>Lemon sales rose to $30.7M from $30M, with higher volume offsetting lower prices. Avocado revenue fell to $5.6M from $7.5M largely due to the lower prices.</li>    <li>\"Strong lemon and orange results in fiscal third quarter were partially offset by reduced avocado pricing due to a record heat that occurred late in the third quarter,\" says CEO Harold Edwards.</li>    <li>The company's narrowed its guidance for the full year, forecasting EPS of $0.65-$0.70 vs. a previous range of $0.65-$0.75.</li>    <li>It expects to sell 3.2M-3.4M cartons of fresh lemons at average price of $25.50/carton (up from previous expectations for 3.1M-3.3M cartons at average $24.50 each). It's forecasting sales of 6.3M pounds of avocados at average $1.04/lb, vs. previous expectations for 6M-6.5M pounds at $1.30/pound.</li>    <li><a href=\"https://seekingalpha.com/pr/17265531-limoneira-company-announces-third-quarter-fiscal-year-2018-financial-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3389213\" data-linked=\"Limoneira -16% as profits miss amid avocado decline\" data-tweet=\"$LMNR - Limoneira -16% as profits miss amid avocado decline https://seekingalpha.com/news/3389213-limoneiraminus-16-profits-miss-amid-avocado-decline?source=tweet\" data-url=\"https://seekingalpha.com/news/3389213-limoneiraminus-16-profits-miss-amid-avocado-decline\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389210\" data-ts=\"1536615415\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARTX\" target=\"_blank\">ARTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389210-after-hours-gainers-losers-09-10-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (09/10/2018)</a></h4><ul><li><b>Top Gainers:</b> <a href='https://seekingalpha.com/symbol/ARTX' title='Arotech Corporation'>ARTX</a> <font color='green'>+5.3%</font>. <a href='https://seekingalpha.com/symbol/NTNX' title='Nutanix'>NTNX</a> <font color='green'>+4.1%</font>. <a href='https://seekingalpha.com/symbol/SU' title='Suncor Energy Inc.'>SU</a> <font color='green'>+3.8%</font>. <a href='https://seekingalpha.com/symbol/TRXC' title='TransEnterix, Inc.'>TRXC</a> <font color='green'>+2.3%</font>. <a href='https://seekingalpha.com/symbol/RIGL' title='Rigel Pharmaceuticals, Inc.'>RIGL</a> <font color='green'>+2.1%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/LMNR' title='Limoneira'>LMNR</a> <font color='red'>-15.9%</font>. <a href='https://seekingalpha.com/symbol/SONO' title='Sonos, Inc.'>SONO</a> <font color='red'>-13.4%</font>. <a href='https://seekingalpha.com/symbol/ECYT' title='Endocyte, Inc.'>ECYT</a> <font color='red'>-4.1%</font>. <a href='https://seekingalpha.com/symbol/LAKE' title='Lakeland Industries, Inc.'>LAKE</a> <font color='red'>-3.3%</font>. <a href='https://seekingalpha.com/symbol/AT' title='Atlantic Power Corporation'>AT</a> <font color='red'>-2.3%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389210\" data-linked=\"After Hours Gainers / Losers (09/10/2018)\" data-tweet=\"$ARTX $ARTX $NTNX - After Hours Gainers / Losers (09/10/2018) https://seekingalpha.com/news/3389210-after-hours-gainers-losers-09-10-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3389210-after-hours-gainers-losers-09-10-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389207\" data-ts=\"1536614364\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BSGM\" target=\"_blank\">BSGM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389207-biosig-tech-reverse-spits-shares-1-2_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioSig Tech reverse spits shares 1:2.5</a></h4><ul><li>Aime at a Nasdaq uplisting, BioSig Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/BSGM' title='BioSig Technologies, Inc.'>BSGM</a>) <a href=\"https://seekingalpha.com/pr/17265633-biosig-technologies-inc-announces-1minus-2_5-reverse-stock-split-pending-uplist-nasdaq\" target=\"_blank\">executed</a> a 1:2.5 reverse split of its common stock after the close. Post-split trading commences tomorrow, September 11.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389207\" data-linked=\"BioSig Tech reverse spits shares 1:2.5\" data-tweet=\"$BSGM - BioSig Tech reverse spits shares 1:2.5 https://seekingalpha.com/news/3389207-biosig-tech-reverse-spits-shares-1-2_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3389207-biosig-tech-reverse-spits-shares-1-2_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389193\" data-ts=\"1536612491\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDMO\" target=\"_blank\">CDMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389193-avid-bioservices-fq1-top-line-down-54-shares-up-14-after-hours-on-consensus-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avid Bioservices FQ1 top line down 54%; shares up 14% after hours on consensus beat</a></h4><ul><li>Avid Bioservices (NASDAQ:<a href='https://seekingalpha.com/symbol/CDMO' title='Avid Bioservices, Inc.'>CDMO</a>) <a href=\"https://seekingalpha.com/pr/17265546-avid-bioservices-reports-financial-results-first-quarter-fiscal-2019-recent-developments\" target=\"_blank\">fiscal Q1 </a>contract revenue was $12.6M, down 53.5% from a year ago due the delay in shipping of $9.9M of completed product and from softer demand from its two largest customers.</li><li>Current backlog is $39M.</li><li><strong>Fiscal 2019 guidance</strong>: Revenue: $51M - 55M.</li><li>Shares are up&nbsp;<font color='green'>14%</font>&nbsp;after hours.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3389166-avid-bioservices-beats-0_07-beats-revenue\" target=\"_blank\">Avid Bioservices beats by $0.07, beats on revenue</a> (Sept. 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3389193\" data-linked=\"Avid Bioservices FQ1 top line down 54%; shares up 14% after hours on consensus beat\" data-tweet=\"$CDMO - Avid Bioservices FQ1 top line down 54%; shares up 14% after hours on consensus beat https://seekingalpha.com/news/3389193-avid-bioservices-fq1-top-line-down-54-shares-up-14-after-hours-on-consensus-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3389193-avid-bioservices-fq1-top-line-down-54-shares-up-14-after-hours-on-consensus-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389192\" data-ts=\"1536612454\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTRX\" target=\"_blank\">MTRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389192-matrix-serviceminus-9_6-q4-profits-fall-short\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Matrix Service -9.6% as Q4 profits fall short</a></h4><ul>   <li>Matrix Service (NASDAQ:<a href='https://seekingalpha.com/symbol/MTRX' title='Matrix Service Company'>MTRX</a>) is <font color='red'>off 9.6%</font> after hours following a miss on profits in <a href=\"https://seekingalpha.com/news/3389164-matrix-service-misses-0_04-beats-revenue\" target=\"_blank\">fiscal Q4 earnings</a>.</li>    <li>The company had taken $18M in impairment charges resulting in an EPS of -$0.55; exclusive of that, EPS was $0.03, which missed expectations for $0.07.</li>    <li>\"Backlog at June 30, 2018 increased 79% to $1.219 billion during the year,\" says CEO John Hewitt. \"That said, the majority of these awards came later than expected, pushing revenue into fiscal 2019 and beyond.\"</li>    <li>Book-to-bill ratio was 2.0 for Q4, on project awards of $597.5M.</li>    <li>Backlog is up 33% Q/Q to $1.219B (and up 79% Y/Y as Hewitt noted).</li>    <li>It's guiding to fiscal 2019 revenue of $1.25B-$1.35B and ESP of $0.85-$1.15.</li>    <li><a href=\"https://matrixservicecompany.com/\" target=\"_blank\">Conference call</a> to come tomorrow at 10:30 a.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17265547-matrix-service-company-announces-fiscal-2018-fourth-quarter-full-year-results-provides-fiscal\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3389192\" data-linked=\"Matrix Service -9.6% as Q4 profits fall short\" data-tweet=\"$MTRX - Matrix Service -9.6% as Q4 profits fall short https://seekingalpha.com/news/3389192-matrix-serviceminus-9_6-q4-profits-fall-short?source=tweet\" data-url=\"https://seekingalpha.com/news/3389192-matrix-serviceminus-9_6-q4-profits-fall-short\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389187\" data-ts=\"1536612075\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PACB\" target=\"_blank\">PACB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389187-pacific-bio-readies-stock-offering-shares-down-8-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pacific Bio readies stock offering; shares down 8% after hours</a></h4><ul><li>Pacific Biosciences of California (NASDAQ:<a href='https://seekingalpha.com/symbol/PACB' title='Pacific Biosciences of California'>PACB</a>) slips&nbsp;<font color='red'>8%</font>&nbsp;after hours in reaction to its <a href=\"https://seekingalpha.com/pr/17265526-pacific-biosciences-california-inc-announces-proposed-public-offering-common-stock\" target=\"_blank\">planned stock offering</a>. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389187\" data-linked=\"Pacific Bio readies stock offering; shares down 8% after hours\" data-tweet=\"$PACB - Pacific Bio readies stock offering; shares down 8% after hours https://seekingalpha.com/news/3389187-pacific-bio-readies-stock-offering-shares-down-8-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3389187-pacific-bio-readies-stock-offering-shares-down-8-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389186\" data-ts=\"1536612068\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IRET\" target=\"_blank\">IRET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389186-investors-real-estate-trust-and-nbsp-beats-0_01-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investors Real Estate Trust&amp;nbsp; beats by $0.01, beats on revenue</a></h4><ul><li>Investors Real Estate Trust&nbsp; (NYSE:<a href='https://seekingalpha.com/symbol/IRET' title='Investors Real Estate Trust'>IRET</a>): Q1 Adj. FFO EPS of $0.09 beats by $0.01; FFO of $0.08.</li><li>Real estate revenue&nbsp;of $45.95M (+12.1% Y/Y) <font color='green'>beats by $1.01M</font>.</li><li>Shares <font color='green'>+1.65%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17265601-iret-announces-first-quarter-fiscal-2019-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3389186\" data-linked=\"Investors Real Estate Trust&amp;nbsp; beats by $0.01, beats on revenue\" data-tweet=\"$IRET - Investors Real Estate Trust&amp;nbsp; beats by $0.01, beats on revenue https://seekingalpha.com/news/3389186-investors-real-estate-trust-and-nbsp-beats-0_01-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3389186-investors-real-estate-trust-and-nbsp-beats-0_01-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389179\" data-ts=\"1536611459\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ECYT\" target=\"_blank\">ECYT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389179-endocyte-readies-175m-stock-offering-shares-down-5-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Endocyte readies $175M stock offering; shares down 5% after hours</a></h4><ul><li>Endocyte (NASDAQ:<a href='https://seekingalpha.com/symbol/ECYT' title='Endocyte, Inc.'>ECYT</a>) <a href=\"https://seekingalpha.com/pr/17265567-endocyte-announces-175_0-million-proposed-public-offering-common-stock\" target=\"_blank\">launches </a>a $175M public offering of common stock. Price, volume and terms have yet to be announced.</li><li>Shares are off&nbsp;<font color='red'>5%</font>&nbsp;after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389179\" data-linked=\"Endocyte readies $175M stock offering; shares down 5% after hours\" data-tweet=\"$ECYT - Endocyte readies $175M stock offering; shares down 5% after hours https://seekingalpha.com/news/3389179-endocyte-readies-175m-stock-offering-shares-down-5-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3389179-endocyte-readies-175m-stock-offering-shares-down-5-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389171\" data-ts=\"1536610531\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CASY\" target=\"_blank\">CASY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389171-caseys-general-stores-beats-0_24-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Caseys General Stores beats by $0.24, beats on revenue</a></h4><ul><li>Caseys General Stores (NASDAQ:<a href='https://seekingalpha.com/symbol/CASY' title='Casey&#39;s General Stores, Inc.'>CASY</a>): Q1 GAAP EPS of $1.90 <span style=\"color:green\">beats by $0.24</span>.</li><li>Revenue of $2.59B (+23.9% Y/Y) <font color='green'>beats by $10M</font>.</li><li>Shares <font color='green'>+1.4%</font>.</li><li><a href='https://seekingalpha.com/filing/4165928'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3389171\" data-linked=\"Caseys General Stores beats by $0.24, beats on revenue\" data-tweet=\"$CASY - Caseys General Stores beats by $0.24, beats on revenue https://seekingalpha.com/news/3389171-caseys-general-stores-beats-0_24-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3389171-caseys-general-stores-beats-0_24-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389167\" data-ts=\"1536610231\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AABA\" target=\"_blank\">AABA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389167-altaba-confirms-yahoo-japan-stake-sale-354-share\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Altaba confirms Yahoo Japan stake sale at ¥354/share</a></h4><ul>   <li>Altaba (NASDAQ:<a href='https://seekingalpha.com/symbol/AABA' title='Altaba, Inc.'>AABA</a>) <a href=\"https://seekingalpha.com/pr/17265518-altaba-announces-determination-number-shares-sale-price-offering-shares-yahoo-japan\" target=\"_blank\">confirms plans to exit</a> its entire 1.36B-share stake in Yahoo Japan (<a href='https://seekingalpha.com/symbol/YAHOY' title='Yahoo Japan Corp. ADR'>OTCPK:YAHOY</a>).</li>    <li>In an announcement, the company says it will sell its 1,363,531,700 shares to certain managers in connection with an offering at &yen;354/share (about $3.184/share).</li>    <li>Shares closed in Tokyo at &yen;371, meaning the offering comes at a 4.6% discount.</li>    <li>The shares are expected to be delivered on Friday.</li>    <li>Altaba will use proceeds to repurchase its own common stock and for general purposes.</li>    <li>Today: <a href='https://seekingalpha.com/symbol/AABA' title='Altaba, Inc.'>AABA</a> <font color='red'>-1.6%</font>, <a href='https://seekingalpha.com/symbol/YAHOY' title='Yahoo Japan Corp. ADR'>OTCPK:YAHOY</a> <font color='red'>-0.4%</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3389152-altaba-sell-entire-stake-yahoo-japan\" target=\"_blank\">Altaba to sell entire stake in Yahoo Japan</a> (Sep. 10 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3389167\" data-linked=\"Altaba confirms Yahoo Japan stake sale at ¥354/share\" data-tweet=\"$AABA $AABA $YAHOY - Altaba confirms Yahoo Japan stake sale at ¥354/share https://seekingalpha.com/news/3389167-altaba-confirms-yahoo-japan-stake-sale-354-share?source=tweet\" data-url=\"https://seekingalpha.com/news/3389167-altaba-confirms-yahoo-japan-stake-sale-354-share\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389166\" data-ts=\"1536610229\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDMO\" target=\"_blank\">CDMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389166-avid-bioservices-beats-0_07-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avid Bioservices beats by $0.07, beats on revenue</a></h4><ul><li>Avid Bioservices (NASDAQ:<a href='https://seekingalpha.com/symbol/CDMO' title='Avid Bioservices, Inc.'>CDMO</a>): Q1 GAAP EPS of -$0.06 <span style=\"color:green\">beats by $0.07</span>.</li><li>Revenue of $12.59M (-53.5% Y/Y) <font color='green'>beats by $3.63M</font>.</li><li>Shares <font color='green'>+5.3%</font>.</li><li><a href='https://seekingalpha.com/pr/17265546-avid-bioservices-reports-financial-results-first-quarter-fiscal-2019-recent-developments'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3389166\" data-linked=\"Avid Bioservices beats by $0.07, beats on revenue\" data-tweet=\"$CDMO - Avid Bioservices beats by $0.07, beats on revenue https://seekingalpha.com/news/3389166-avid-bioservices-beats-0_07-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3389166-avid-bioservices-beats-0_07-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389158\" data-ts=\"1536609541\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATUS\" target=\"_blank\">ATUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389158-altice-usa-launches-residential-gigabit-fiber-service\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Altice USA launches residential gigabit fiber service</a></h4><ul>    <li>Altice USA (<a href=\"http://seekingalpha.com/symbol/ATUS\" target=\"_blank\">ATUS</a> <font color='green'>+2.7%</font>) has launched its <a href=\"https://seekingalpha.com/pr/17265496-altice-usa-unveils-advanced-residential-fiber-home-service-nation-altice-gigabit-fiber\" target=\"_blank\">residential gigabit fiber service</a>, with initial availability in parts of Long Island, N.Y.</li>    <li>The symmetrical service comes via a new fiber-to-the-home network and an all-in-one fiber gateway device, \"the first all-in-one integrated giga-optics router and smart WiFi device offered by an MSO in the United States.\"</li>    <li>The company plans further rollouts to the rest of Long Island and throughout its New York area footprint as development continues.</li>    <li>Meanwhile, it's also working to increase speeds on its hybrid fiber-coaxial network, of up to 400 Mbps for residential customers.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3389158\" data-linked=\"Altice USA launches residential gigabit fiber service\" data-tweet=\"$ATUS - Altice USA launches residential gigabit fiber service https://seekingalpha.com/news/3389158-altice-usa-launches-residential-gigabit-fiber-service?source=tweet\" data-url=\"https://seekingalpha.com/news/3389158-altice-usa-launches-residential-gigabit-fiber-service\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389157\" data-ts=\"1536608921\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLL\" target=\"_blank\">BLL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389157-ballplus-2-after-winning-deal-to-build-geiger-mode-lidar-cameras\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ball +2% after winning deal to build Geiger-mode LIDAR cameras</a></h4><ul>     <li>Ball Corp. (<a href='https://seekingalpha.com/symbol/BLL' title='Ball Corporation'>BLL</a> <font color='green'>+1.9%</font>) is higher after <a href=\"https://seekingalpha.com/pr/17265360-ball-aerospace-receives-exclusive-license-build-geiger-mode-lidar-cameras-defense-aerospace\" target=\"_blank\">signing an exclusive license agreement</a> to be the sole  manufacturer of the Geiger-mode avalanche photodiode light  detection and ranging cameras for the defense and aerospace  industries.</li><li>GmAPD camera technology creates an accurate 3-D representation of  wide-area terrain and offers the ability to \"see through\" dense foliage  and other obscurants at significantly longer distances.</li>     <li>BLL describes the technology as a critical component to non-conventional imaging and intelligence, surveillance and reconnaissance systems which are used in  U.S. Department of Defense, space and other government missions.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3389157\" data-linked=\"Ball +2% after winning deal to build Geiger-mode LIDAR cameras\" data-tweet=\"$BLL - Ball +2% after winning deal to build Geiger-mode LIDAR cameras https://seekingalpha.com/news/3389157-ballplus-2-after-winning-deal-to-build-geiger-mode-lidar-cameras?source=tweet\" data-url=\"https://seekingalpha.com/news/3389157-ballplus-2-after-winning-deal-to-build-geiger-mode-lidar-cameras\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389152\" data-ts=\"1536607685\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AABA\" target=\"_blank\">AABA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389152-altaba-to-sell-entire-stake-in-yahoo-japan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Altaba to sell entire stake in Yahoo Japan</a></h4><ul>   <li>Altaba (<a href=\"http://seekingalpha.com/symbol/AABA\" target=\"_blank\">AABA</a> <font color='red'>-1.7%</font>) has boosted a planned <a href=\"https://seekingalpha.com/filing/4164917\" target=\"_blank\">stake sale</a> in Yahoo Japan (<a href=\"http://seekingalpha.com/symbol/YAHOY\" target=\"_blank\">YAHOY</a> <font color='red'>-0.5%</font>) to exit the position entirely.</li>    <li>The left-behind financial remnants of the former Yahoo, Altaba had previously planned to sell about 750M shares of Yahoo Japan to raise $2.5B. (h/t Bloomberg)</li>    <li>Now it will sell its entire holding of just over 1.36B shares at what's expected to be a 3-5% discount to last close.</li>    <li>Final offering terms will be set by 8 a.m. Tuesday Tokyo time.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3389152\" data-linked=\"Altaba to sell entire stake in Yahoo Japan\" data-tweet=\"$AABA $AABA $YAHOY - Altaba to sell entire stake in Yahoo Japan https://seekingalpha.com/news/3389152-altaba-to-sell-entire-stake-in-yahoo-japan?source=tweet\" data-url=\"https://seekingalpha.com/news/3389152-altaba-to-sell-entire-stake-in-yahoo-japan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389151\" data-ts=\"1536606717\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BOJA\" target=\"_blank\">BOJA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389151-restaurant-chains-highest-exposure-to-hurricane-florence\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Restaurant chains with highest exposure to Hurricane Florence</a></h4><ul><li>Bojangles (NASDAQ:<a href='https://seekingalpha.com/symbol/BOJA' title='Bojangles&#39;'>BOJA</a>) is&nbsp;<font color='red'>down 1.8%&nbsp;</font>on the day with Hurricane Florence due to a make landfall in the U.S. across a region where the chain has one of the higher mixes of restaurants in the sector.</li><li>Some data crunching by the SunTrust analyst team indicates that 59% of Bojangles' stores are located in the Carolinas.</li><li>Carrols Restaurant (<a href='https://seekingalpha.com/symbol/TAST' title='Carrols Restaurant Group, Inc.'>TAST</a> <font color='green'>+0.3%</font>) with&nbsp; 23% exposure to the Carolinas and Zoe's Kitchen (<a href='https://seekingalpha.com/symbol/ZOES' title='Zoe&#39;s Kitchen'>ZOES</a> <font color='red'>-1.7%</font>) with 12% exposure are also risk at seeing some sales drops for the weekend.</li><li>Sources: Restaurants News, Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3389151\" data-linked=\"Restaurant chains with highest exposure to Hurricane Florence\" data-tweet=\"$BOJA $BOJA $TAST - Restaurant chains with highest exposure to Hurricane Florence https://seekingalpha.com/news/3389151-restaurant-chains-highest-exposure-to-hurricane-florence?source=tweet\" data-url=\"https://seekingalpha.com/news/3389151-restaurant-chains-highest-exposure-to-hurricane-florence\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389149\" data-ts=\"1536606307\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSC-OLD\" target=\"_blank\">SSC-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389149-ideanomics-names-co-ceo-two-others-to-executive-suite\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ideanomics names co-CEO, two others to executive suite</a></h4><ul>   <li>Ideanomics (<a href=\"http://seekingalpha.com/symbol/SSC\" target=\"_blank\">SSC</a> <font color='green'>+3.3%</font>) -- the former Seven Stars Cloud -- has named Brett McGonegal its <a href=\"https://seekingalpha.com/pr/17264804-ideanomics-appoints-brett-mcgonegal-co-ceo-adds-senior-executives\" target=\"_blank\">co-chief executive officer</a>, alongside Bruno Wu.</li>    <li>McGonegal is the former CEO of Hong Kong-listed investment bank The Reorient Group, which was sold to Alibaba's Jack Ma and his associates in 2015.</li>    <li>That move is effective Sept. 21.</li>    <li>In other executive additions, Uwe Parpart (chairman of Asia Times Holdings) is joining the company as chief strategy officer. Prior to Asia Times, Parpart was also at Reorient Group as chief strategist and head of research.</li>    <li>And Eval Kalimtgis will join as chief investment officer and head of financial product development. He was most recently founder of the Strategic Portfolio Group at JPMorgan's CIO division in London.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3389149\" data-linked=\"Ideanomics names co-CEO, two others to executive suite\" data-tweet=\"$SSC-OLD - Ideanomics names co-CEO, two others to executive suite https://seekingalpha.com/news/3389149-ideanomics-names-co-ceo-two-others-to-executive-suite?source=tweet\" data-url=\"https://seekingalpha.com/news/3389149-ideanomics-names-co-ceo-two-others-to-executive-suite\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389148\" data-ts=\"1536606302\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZAGG\" target=\"_blank\">ZAGG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389148-zaggplus-5-after-roth-capital-pt-boost\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zagg +5% after Roth Capital PT boost</a></h4><ul><li>Zagg (NASDAQ:<a href='https://seekingalpha.com/symbol/ZAGG' title='ZAGG Inc'>ZAGG</a>) is&nbsp;<font color='green'>up 5%</font>&nbsp;after Roth Capital lifts its price target to $16.50 from $16.00 on a favorable view of the company's analyst day presentation.</li><li>Growth in Zagg's Morphie wireless charging business is seen offsetting declines in power case sales.</li><li>Zagg has traded in a range of $10.90 to $23.70 over the last 52 weeks.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389148\" data-linked=\"Zagg +5% after Roth Capital PT boost\" data-tweet=\"$ZAGG - Zagg +5% after Roth Capital PT boost https://seekingalpha.com/news/3389148-zaggplus-5-after-roth-capital-pt-boost?source=tweet\" data-url=\"https://seekingalpha.com/news/3389148-zaggplus-5-after-roth-capital-pt-boost\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389142\" data-ts=\"1536605408\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RMNI\" target=\"_blank\">RMNI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389142-technology-top-5-gainers-losers-of-2_50-pm-09-10-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 2.50 PM (09/10/2018)</a></h4><ul>     <li><strong>Gainers:</strong> <a href='https://seekingalpha.com/symbol/RMNI' title='Rimini Street'>RMNI</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/PAR' title='PAR Technology Corporation'>PAR</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/NPTN' title='NeoPhotonics Corporation'>NPTN</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/NINE' title='Nine Energy Service, Inc.'>NINE</a> <font color='green'>+8%</font>.</li>      <li><strong>Losers:</strong> <a href='https://seekingalpha.com/symbol/MOXC' title='Moxian, Inc.'>MOXC</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/IPDN' title='Professional Diversity Network'>IPDN</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/SAIC' title='Science Applications International Corporation'>SAIC</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/ATHM' title='Autohome Inc.'>ATHM</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a> <font color='red'>-9%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3389142\" data-linked=\"Technology - Top 5 Gainers / Losers as of 2.50 PM (09/10/2018)\" data-tweet=\"$RMNI $RMNI $PAR - Technology - Top 5 Gainers / Losers as of 2.50 PM (09/10/2018) https://seekingalpha.com/news/3389142-technology-top-5-gainers-losers-of-2_50-pm-09-10-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3389142-technology-top-5-gainers-losers-of-2_50-pm-09-10-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389141\" data-ts=\"1536605312\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TAHO\" target=\"_blank\">TAHO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389141-tahoe-resourcesminus-4-amid-continued-uncertainty-over-escobal-mine-restart\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tahoe Resources -4% amid continued uncertainty over Escobal mine restart</a></h4><ul>     <li>Tahoe Resources (<a href='https://seekingalpha.com/symbol/TAHO' title='Tahoe Resources Inc.'>TAHO</a> <font color='red'>-4.2%</font>) <a href=\"https://www.reuters.com/article/us-tahoe-resources-guatemala/tahoe-aims-to-work-in-good-faith-to-restart-guatemala-mine-idUSKCN1LQ252\" target=\"_blank\">will work \"in good faith\"</a> with Guatemalan officials and locals to resolve a dispute and resume operations at its Escobal silver mine, CEO Jim Voorhees tells investors on conference call to discuss the dispute.</li>     <li>The CEO says the miner remains financially sound and says Tahoe's credit facilities have no ties to Escobal and that its gold mines in Peru and elsewhere are enough to support the  company's balance sheet for the time being.</li><li>Voorhees says similar disputes in Guatemala have been settled in six months or less,  although a similar outcome in this case is not certain.</li>     <li>Guatemala's Constitutional Court <a href=\"https://seekingalpha.com/news/3387440-tahoe-resources-minus-10-percent-guatemala-court-suspends-escobal-mine-license\" target=\"_blank\">last week</a> upheld the suspension of licenses at Escobal mine from July 2017 after an anti-mining group alleged that the country's Ministry of Energy and Mines did not consult with the Xinca indigenous people before awarding the Escobal mining license to Tahoe.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3389141\" data-linked=\"Tahoe Resources -4% amid continued uncertainty over Escobal mine restart\" data-tweet=\"$TAHO - Tahoe Resources -4% amid continued uncertainty over Escobal mine restart https://seekingalpha.com/news/3389141-tahoe-resourcesminus-4-amid-continued-uncertainty-over-escobal-mine-restart?source=tweet\" data-url=\"https://seekingalpha.com/news/3389141-tahoe-resourcesminus-4-amid-continued-uncertainty-over-escobal-mine-restart\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389140\" data-ts=\"1536604978\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORXOF\" target=\"_blank\">ORXOF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389140-teva-comes-up-short-in-patent-dispute-orexo-ab\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teva comes up short in patent dispute with Orexo AB</a></h4><ul><li>Orexo AB (<a href='https://seekingalpha.com/symbol/ORXOF' title='Orexo AB'>OTC:ORXOF</a>)(<a href='https://seekingalpha.com/symbol/ORXOY' title='Orexo AB ADR'>OTCQX:ORXOY</a>) has <a href=\"https://in.reuters.com/article/us-teva-orexo-zubsolv/orexo-soars-after-winning-opioid-drug-appeal-against-teva-idINKCN1LQ290\" target=\"_blank\">prevailed </a>in an appeal of a patent dispute with Teva Pharmaceutical Industries (<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color='red'>-1.3%</font>) over the latter's plan to market a generic version of opioid dependence treatment <a href=\"https://www.zubsolv.com/\" target=\"_blank\">Zubsolv </a>(buprenorphine and naloxone). The appeals court said that Teva failed to sufficiently establish that Orexo's patent claims were \"obvious\" and therefore unpatentable.</li><li>Orexo's ADRs ended the session up&nbsp;<font color='green'>44%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389140\" data-linked=\"Teva comes up short in patent dispute with Orexo AB\" data-tweet=\"$ORXOF $ORXOF $ORXOY - Teva comes up short in patent dispute with Orexo AB https://seekingalpha.com/news/3389140-teva-comes-up-short-in-patent-dispute-orexo-ab?source=tweet\" data-url=\"https://seekingalpha.com/news/3389140-teva-comes-up-short-in-patent-dispute-orexo-ab\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389133\" data-ts=\"1536602518\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TGA\" target=\"_blank\">TGA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389133-energy-materials-top-5-gainers-losers-of-2-00-pm-09-10-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (09/10/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/TGA' title='Transglobe Energy Corp'>TGA</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/LBRT' title='Liberty Oilfield Services Inc.'>LBRT</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/ROSE' title='Rosehill Resources Inc.'>ROSE</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/FTSI' title='FTS International, Inc.'>FTSI</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/CENX' title='Century Aluminum Company'>CENX</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/PGLC' title='Pershing Gold Corporation'>PGLC</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/ZN' title='Zion Oil & Gas Inc'>ZN</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/CHNR' title='China Natural Resources, Inc.'>CHNR</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/TRCH' title='Torchlight Energy Resources, Inc.'>TRCH</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/TAT' title='TransAtlantic Petroleum Ltd.'>TAT</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389133\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (09/10/2018)\" data-tweet=\"$TGA $TGA $LBRT - Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (09/10/2018) https://seekingalpha.com/news/3389133-energy-materials-top-5-gainers-losers-of-2-00-pm-09-10-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3389133-energy-materials-top-5-gainers-losers-of-2-00-pm-09-10-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389132\" data-ts=\"1536602447\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QCOM\" target=\"_blank\">QCOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389132-qualcomm-launches-new-android-watch-processor\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qualcomm launches new Android watch processor</a></h4><ul><li>        Qualcomm (<a href='https://seekingalpha.com/symbol/QCOM' title='Qualcomm Inc.'>QCOM</a> <font color='green'>+3.2%</font>) <a href=\"https://seekingalpha.com/pr/17265336-qualcomm-snapdragon-wear-3100-platform-supports-new-ultra-low-power-system-architecture-next\" target=\"_blank\">is releasing</a> the Snapdragon Wear 3100, a new processor for Android (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a> <font color='red'>-0.1%</font>)(<a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a> <font color='red'>-0.2%</font>) watches meant to extend battery life, enhance displays, and offer more versatility for wearables.</li><li>               The chip adds a secondary low-power processor that&rsquo;s intended to handle most of the work when the wearable isn&rsquo;t in use (so for things like the sensors and ambient display). Qualcomm says the co-processor will use up to 20x less energy than the main processor.&nbsp;</li><li>               Regarding battery improvement, Qualcomm estimates a typical Wear OS smartwatch will get over a day of battery life, about five hours longer than current models.&nbsp;</li><li>               Another interesting update is the fact that Qualcomm will now let hardware companies write their own code to read heart rate or other data. In the past, companies had to rely on Qualcomm algorithms.&nbsp;</li><li>               The first Wear 3100 chip-enabled watches will ship before year&rsquo;s end with models coming from Fossil, Louis Vuitton, and Montblanc.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3389132\" data-linked=\"Qualcomm launches new Android watch processor\" data-tweet=\"$QCOM $QCOM $GOOG - Qualcomm launches new Android watch processor https://seekingalpha.com/news/3389132-qualcomm-launches-new-android-watch-processor?source=tweet\" data-url=\"https://seekingalpha.com/news/3389132-qualcomm-launches-new-android-watch-processor\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389126\" data-ts=\"1536600546\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GDOT\" target=\"_blank\">GDOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389126-green-dot-rallies-on-suntrust-confidence\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Green Dot rallies on SunTrust confidence</a></h4><ul><li>Green Dot (<a href='https://seekingalpha.com/symbol/GDOT' title='Green Dot Corporation'>GDOT</a> <font color='green'>+1.7%</font>) rallies after SunTrust lifts its price target on the payments stock to a Street-high $105.</li><li>The analyst team expects Green Dot to maintain double-digit organic revenue and EBITDA growth on the strength of new mobile banking initiatives and new payroll solution programs.</li><li>The 52-week high for Green Dot is $87.13.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389126\" data-linked=\"Green Dot rallies on SunTrust confidence\" data-tweet=\"$GDOT - Green Dot rallies on SunTrust confidence https://seekingalpha.com/news/3389126-green-dot-rallies-on-suntrust-confidence?source=tweet\" data-url=\"https://seekingalpha.com/news/3389126-green-dot-rallies-on-suntrust-confidence\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389124\" data-ts=\"1536598873\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NMIH\" target=\"_blank\">NMIH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389124-financials-top-5-gainers-losers-of-1-00-pm-09-10-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM (09/10/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/NMIH' title='NMI Holdings, Inc.'>NMIH</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/SIEB' title='Siebert Financial Corp.'>SIEB</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/OXBR' title='Oxbridge Re Holdings Limited'>OXBR</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/KKR' title='KKR'>KKR</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/AFIN' title='American Finance Trust, Inc'>AFIN</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/LTS' title='Ladenburg Thalmann Financial Services Inc.'>LTS</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/JP' title='Jupai Holdings'>JP</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/PPDF' title='PPDAI Group Inc.'>PPDF</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/NOAH' title='Noah Holdings Limited'>NOAH</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/SUPV' title='Grupo Supervielle'>SUPV</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389124\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM (09/10/2018)\" data-tweet=\"$NMIH $NMIH $SIEB - Financials - Top 5 Gainers / Losers as of 1:00 PM (09/10/2018) https://seekingalpha.com/news/3389124-financials-top-5-gainers-losers-of-1-00-pm-09-10-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3389124-financials-top-5-gainers-losers-of-1-00-pm-09-10-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389123\" data-ts=\"1536598717\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMG\" target=\"_blank\">CMG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389123-hedgeye-sees-huge-upside-for-chipotle\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hedgeye sees huge upside for Chipotle</a></h4><ul> <li><a href=\"https://app.hedgeye.com/\" target=\"_blank\">Hedgeye</a> calls Chipotle (<a href='https://seekingalpha.com/symbol/CMG' title='Chipotle Mexican Grill, Inc.'>CMG</a> <font color='green'>+1.2%</font>) one of the best long-term picks in the restaurant sector on its view the company will leverage opportunities tied to a second make-line for mobile ordering.</li> <li>The research firm sees Chipotle's 2021 EPS about 50% higher than where the current consensus analysts estimate stands. Shares of Chipotle are also seen as having 50% upside potential.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3389123\" data-linked=\"Hedgeye sees huge upside for Chipotle\" data-tweet=\"$CMG - Hedgeye sees huge upside for Chipotle https://seekingalpha.com/news/3389123-hedgeye-sees-huge-upside-for-chipotle?source=tweet\" data-url=\"https://seekingalpha.com/news/3389123-hedgeye-sees-huge-upside-for-chipotle\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389122\" data-ts=\"1536598611\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FRED\" target=\"_blank\">FRED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389122-midday-gainers-losers-09-10-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (09/10/2018)</a></h4><ul>     <li><strong>Gainers:</strong> <a href='https://seekingalpha.com/symbol/FRED' title='Fred&#39;s, Inc.'>FRED</a> <font color='green'>+66%</font>. <a href='https://seekingalpha.com/symbol/RMNI' title='Rimini Street'>RMNI</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/DCTH' title='Delcath Systems, Inc.'>OTC:DCTH</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/PRQR' title='ProQR Therapeutics'>PRQR</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/NMIH' title='NMI Holdings, Inc.'>NMIH</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/OBLN' title='Obalon Therapeutics'>OBLN</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/SIEB' title='Siebert Financial Corp.'>SIEB</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/FTEK' title='Fuel Tech, Inc.'>FTEK</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/NEWA' title='Newater Technology, Inc.'>NEWA</a> <font color='green'>+10%</font>.</li>      <li><strong>Losers:</strong> <a href='https://seekingalpha.com/symbol/AYTU' title='Aytu BioScience, Inc.'>AYTU</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/ACOR' title='Acorda Therapeutics, Inc.'>ACOR</a> <font color='red'>-22%</font>. SHLD <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/ATAI' title='ATA Inc.'>ATAI</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/PGLC' title='Pershing Gold Corporation'>PGLC</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/XBIT' title='Xbiotech'>XBIT</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/ASCMA' title='Ascent Capital Group, Inc.'>ASCMA</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/RRTS' title='Roadrunner Transportation Systems, Inc.'>RRTS</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/KANG' title='iKang Healthcare Group, Inc.'>KANG</a> <font color='red'>-13%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3389122\" data-linked=\"Midday Gainers / Losers (09/10/2018)\" data-tweet=\"$FRED $FRED $RMNI - Midday Gainers / Losers (09/10/2018) https://seekingalpha.com/news/3389122-midday-gainers-losers-09-10-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3389122-midday-gainers-losers-09-10-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389121\" data-ts=\"1536598264\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RNKLF\" target=\"_blank\">RNKLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389121-royal-nickel-doubles-after-huge-gold-discovery-australian-mine\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Royal Nickel doubles after huge gold discovery at Australian mine</a></h4><ul>     <li>Shares of Canadian junior miner Royal Nickel (<a href='https://seekingalpha.com/symbol/RNKLF' title='Royal Nickel Corp.'>OTCQX:RNKLF</a> <font color='green'>+92.9%</font>) roughly double after <a href=\"https://www.cnbc.com/2018/09/10/australia-gold-find-called-once-in-a-lifetime-discovery.html\" target=\"_blank\">discovering gold deposits</a> in Western Australia totaling more than A$15M (US$10.66M).</li>     <li>The unearthed specimens - with the largest weighing nearly 200 lbs. and covered in 2,300 oz. of gold valued at ~A$3.8M (US$2.7M) - were found in the Beta Hunt mine, which the company has been trying to sell.</li><li>To put the discovery into perspective, the Beta Hunt mine normally  produces ore that contains 2-4 g/ton of gold,  considered a standard amount, but the latest find <a href=\"https://business.financialpost.com/news/royal-nickel-surges-83-after-striking-a-mother-lode-of-gold-at-australian-mine\" target=\"_blank\">contains 2K g/ton of gold</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389121\" data-linked=\"Royal Nickel doubles after huge gold discovery at Australian mine\" data-tweet=\"$RNKLF - Royal Nickel doubles after huge gold discovery at Australian mine https://seekingalpha.com/news/3389121-royal-nickel-doubles-after-huge-gold-discovery-australian-mine?source=tweet\" data-url=\"https://seekingalpha.com/news/3389121-royal-nickel-doubles-after-huge-gold-discovery-australian-mine\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>407&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389117\" data-ts=\"1536597151\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCAU\" target=\"_blank\">FCAU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389117-tiger-globals-stake-in-fiat-tops-1b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tiger Global&#39;s stake in Fiat tops $1B</a></h4><ul> <li>Tiger Global is now the fourth largest shareholder of Fiat Chrysler Automobiles (<a href='https://seekingalpha.com/symbol/FCAU' title='Fiat Chrysler Automobiles NV'>FCAU</a> <font color='green'>+1.9%</font>)&nbsp;after bumping up its stake to 59.67M shareas as of September 3.</li> <li>The new position is more than double the stake held by Tiger Global at the end of June.</li> <li>Tiger's holdings in Fiat are now worth more than $1B after today's share price rally.</li> <li><a href=\"https://www.afm.nl/en/professionals/registers/meldingenregisters/substantiele-deelnemingen/details?id=62622\" target=\"_blank\">Netherlands Authority for the Financial Markets filing</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3389117\" data-linked=\"Tiger Global&#39;s stake in Fiat tops $1B\" data-tweet=\"$FCAU - Tiger Global&#39;s stake in Fiat tops $1B https://seekingalpha.com/news/3389117-tiger-globals-stake-in-fiat-tops-1b?source=tweet\" data-url=\"https://seekingalpha.com/news/3389117-tiger-globals-stake-in-fiat-tops-1b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389110\" data-ts=\"1536596070\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMD\" target=\"_blank\">AMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389110-amdplus-6_5-susquehanna-sees-gains-in-cpu-share\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMD +6.5% as Susquehanna sees gains in CPU share</a></h4><ul><li>        Susquehanna<a href=\"https://www.marketwatch.com/story/amd-picking-up-share-in-cpus-says-susquehanna-2018-09-10\" target=\"_blank\"> says</a> AMD (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>) is picking up market share in desktops and laptops with Ryzen Mobile showing &ldquo;signs of life.&rdquo;</li><li>               Analyst Chris Rolland cites his recent analysis showing that &ldquo;most data points for AMD were constructive.&rdquo;&nbsp;</li><li>               While the success is a negative for Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>), Rolland says Intel still has a strong mix with desktop ASPs up 4% Q/Q.&nbsp;</li><li>               Rolland has a Neutral rating on AMD and a Positive rating on Intel. &nbsp;&nbsp;&nbsp;</li><li>               AMD shares are&nbsp;<font color='green'>up 6.5%</font>&nbsp;to $29.13.&nbsp;</li><li>               Intel shares are&nbsp;<font color='red'>down 0.2%</font>&nbsp;to $46.36.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3389110\" data-linked=\"AMD +6.5% as Susquehanna sees gains in CPU share\" data-tweet=\"$AMD $AMD $INTC - AMD +6.5% as Susquehanna sees gains in CPU share https://seekingalpha.com/news/3389110-amdplus-6_5-susquehanna-sees-gains-in-cpu-share?source=tweet\" data-url=\"https://seekingalpha.com/news/3389110-amdplus-6_5-susquehanna-sees-gains-in-cpu-share\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>131&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389103\" data-ts=\"1536595255\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TIS\" target=\"_blank\">TIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389103-consumer-top-5-gainers-losers-of-12-00-pm-09-10-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top 5 Gainers / Losers as of 12:00 PM (09/10/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/TIS' title='Orchids Paper Products Company'>TIS</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/SONO' title='Sonos, Inc.'>SONO</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/TPB' title='Turning Point Brands'>TPB</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/MYE' title='Myers Industries, Inc.'>MYE</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ESND' title='Essendant'>ESND</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/WPRT' title='Westport Fuel Systems, Inc.'>WPRT</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/KBSF' title='KBS Fashion Group Limited'>KBSF</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/DFBG-OLD' title='Differential Brands Group Inc.'>DFBG-OLD</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389103\" data-linked=\"Consumer - Top 5 Gainers / Losers as of 12:00 PM (09/10/2018)\" data-tweet=\"$TIS $TIS $SONO - Consumer - Top 5 Gainers / Losers as of 12:00 PM (09/10/2018) https://seekingalpha.com/news/3389103-consumer-top-5-gainers-losers-of-12-00-pm-09-10-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3389103-consumer-top-5-gainers-losers-of-12-00-pm-09-10-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389090\" data-ts=\"1536593902\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HD\" target=\"_blank\">HD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389090-home-improvement-rally-ahead-of-hurricane\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Home improvement rally ahead of hurricane</a></h4><ul> <li>Home improvement retailers Home Depot (NYSE:<a href='https://seekingalpha.com/symbol/HD' title='Home Depot, Inc.'>HD</a>) and Lowe's (NYSE:<a href='https://seekingalpha.com/symbol/LOW' title='Lowe&#39;s Companies, Inc.'>LOW</a>)&nbsp;both hit new all-time highs this morning.</li> <li>Home Depot is <font color='green'>up 1.86%</font> and traded as high as $211.62.</li> <li>Lowe's is <font color='green'>2.30% higher</font> and traded as high as $112.51.</li> <li>While sentiment in general on the pair is very positive, there is also a major hurricane brewing in the Atlantic that could lead to some extra sales in North Carolina, South Carolina and Virginia. Hurricane Florence is due to make U.S. landfall sometime on Thursday evening.</li><li>Lumber Liquidators (<a href='https://seekingalpha.com/symbol/LL' title='Lumber Liquidators Holdings, Inc.'>LL</a> <font color='green'>+1.2%</font>) is also ahead of broad market averages on the day, with hurricane-related sales a potential factor.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3389090\" data-linked=\"Home improvement rally ahead of hurricane\" data-tweet=\"$HD $HD $LOW - Home improvement rally ahead of hurricane https://seekingalpha.com/news/3389090-home-improvement-rally-ahead-of-hurricane?source=tweet\" data-url=\"https://seekingalpha.com/news/3389090-home-improvement-rally-ahead-of-hurricane\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389081\" data-ts=\"1536592574\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRRK\" target=\"_blank\">SRRK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389081-scholar-rock-up-12\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Scholar Rock up 12%</a></h4><ul><li>Thinly traded Scholar Rock Holding (<a href='https://seekingalpha.com/symbol/SRRK' title='Scholar Rock Holding'>SRRK</a> <font color='green'>+11.5%</font>) is up on below-average volume. Shares are up over&nbsp;<font color='green'>60%</font>&nbsp;since touching $15.55 on August 30 when Pfizer <a href=\"https://seekingalpha.com/news/3386920-pfizers-domagrozumab-exit-dmd-pressures-scholar-rock-9-percent\" target=\"_blank\">announced </a>the termination of development of domagrozumab for DMD. Investors headed for the exits on the perceived bleed-over to latent myostatin inhibitor SRK-015. Bargain hunters have, no doubt, welcomed the buying opportunity.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389081\" data-linked=\"Scholar Rock up 12%\" data-tweet=\"$SRRK - Scholar Rock up 12% https://seekingalpha.com/news/3389081-scholar-rock-up-12?source=tweet\" data-url=\"https://seekingalpha.com/news/3389081-scholar-rock-up-12\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389076\" data-ts=\"1536592061\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RTEC\" target=\"_blank\">RTEC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389076-rudolph-techplus-2_5-on-sidoti-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rudolph Tech +2.5% on Sidoti upgrade</a></h4><ul><li>        Sidoti <a href=\"https://www.streetinsider.com/Upgrades/Sidoti+Upgrades+Rudolph+Technologies+%28RTEC%29+to+Buy/14591727.html\" target=\"_blank\">upgrades</a> Rudolph Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/RTEC' title='Rudolph Technologies, Inc.'>RTEC</a>) from Neutral to Buy, sending shares&nbsp;<font color='green'>up 2.5%</font>&nbsp;to $26.30. &nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3389076\" data-linked=\"Rudolph Tech +2.5% on Sidoti upgrade\" data-tweet=\"$RTEC - Rudolph Tech +2.5% on Sidoti upgrade https://seekingalpha.com/news/3389076-rudolph-techplus-2_5-on-sidoti-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3389076-rudolph-techplus-2_5-on-sidoti-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389075\" data-ts=\"1536591744\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NPTN\" target=\"_blank\">NPTN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389075-neophotonicsplus-6_5-on-needham-target-boost\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NeoPhotonics +6.5% on Needham target boost</a></h4><ul><li>        Needham <a href=\"https://www.streetinsider.com/Analyst+Comments/NeoPhotonics+%28NPTN%29+PT+Raised+to+%2412+at+Needham+%26+Company/14590009.html\" target=\"_blank\">maintains</a> a Strong Buy rating on NeoPhotonics (NYSE:<a href='https://seekingalpha.com/symbol/NPTN' title='NeoPhotonics Corporation'>NPTN</a>) and raises the price target from $9 to $12, a 57% upside to Friday&rsquo;s close.</li><li>               NeoPhotonics shares are&nbsp;<font color='green'>up 6.5%</font>&nbsp;to $8.15. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3389075\" data-linked=\"NeoPhotonics +6.5% on Needham target boost\" data-tweet=\"$NPTN - NeoPhotonics +6.5% on Needham target boost https://seekingalpha.com/news/3389075-neophotonicsplus-6_5-on-needham-target-boost?source=tweet\" data-url=\"https://seekingalpha.com/news/3389075-neophotonicsplus-6_5-on-needham-target-boost\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389073\" data-ts=\"1536591650\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRRK\" target=\"_blank\">SRRK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389073-healthcare-top-5-gainers-losers-of-11-00-09-10-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 AM (09/10/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SRRK' title='Scholar Rock Holding'>SRRK</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/DCTH' title='Delcath Systems, Inc.'>OTC:DCTH</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ACOR' title='Acorda Therapeutics, Inc.'>ACOR</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/AYTU' title='Aytu BioScience, Inc.'>AYTU</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/KANG' title='iKang Healthcare Group, Inc.'>KANG</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/IOVA' title='Iovance Biotherapeutics, Inc.'>IOVA</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389073\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 AM (09/10/2018)\" data-tweet=\"$SRRK $SRRK $MNKD - Healthcare - Top 5 Gainers / Losers as of 11:00 AM (09/10/2018) https://seekingalpha.com/news/3389073-healthcare-top-5-gainers-losers-of-11-00-09-10-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3389073-healthcare-top-5-gainers-losers-of-11-00-09-10-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389068\" data-ts=\"1536591338\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IQ\" target=\"_blank\">IQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389068-erosplus-5-on-iqiyi-partnership\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eros +5% on iQiyi partnership</a></h4><ul><li>        Eros International and iQiyi (NASDAQ:<a href='https://seekingalpha.com/symbol/IQ' title='iQIYI, Inc'>IQ</a>) to provide Indian movies through the Chinese streaming service.</li><li>               The Baidu-backed (NASDAQ:<a href='https://seekingalpha.com/symbol/BIDU' title='Baidu, Inc.'>BIDU</a>) iQiyi signed a similar deal with Netflix (NASDAQ:<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a>) last year. Partnerships offer an easier way for foreign companies to comply with China&rsquo;s strict data storage regulations.&nbsp;</li><li>               Eros didn&rsquo;t disclose the financial terms but targets $10M in revenue in the first year of the deal.&nbsp;</li><li>               Chinese viewers will be able to watch about 100 movies at the Eros Now launch next month, but the total will increase to about 1,000 titles in the next year.&nbsp;</li><li>               Eros Now has the rights to over 5K movies in Indian languages and has 10.1M paid subscribers in India. &nbsp;</li><li>               Eros shares are&nbsp;<font color='green'>up 5.4%</font>&nbsp;to $11.65.&nbsp;</li><li>               IQ shares are&nbsp;<font color='red'>down 1.3%</font>&nbsp;to $26.82 as China-exposed stocks to continue to feel the trade war pressure.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3389068\" data-linked=\"Eros +5% on iQiyi partnership\" data-tweet=\"$IQ $IQ $BIDU - Eros +5% on iQiyi partnership https://seekingalpha.com/news/3389068-erosplus-5-on-iqiyi-partnership?source=tweet\" data-url=\"https://seekingalpha.com/news/3389068-erosplus-5-on-iqiyi-partnership\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389064\" data-ts=\"1536590987\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAGD\" target=\"_blank\">SAGD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389064-sativa-growth-to-co-host-first-cannabis-conference-in-utah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sativa Growth to co-host first cannabis conference in Utah</a></h4><ul><li>Sativa Growth International (<a href='https://seekingalpha.com/symbol/SAGD' title='South American Gold Corp.'>OTCPK:SAGD</a> <font color='green'>+3%</font>) will <a href=\"https://seekingalpha.com/pr/17265173-sativa-growth-international-announces-speaker-lineup-utahs-first-cannabis-conference\" target=\"_blank\">partner </a>with Salt Lake City Weekly to host Utah Conn 2018, the first cannabis-related conference in the state.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389064\" data-linked=\"Sativa Growth to co-host first cannabis conference in Utah\" data-tweet=\"$SAGD - Sativa Growth to co-host first cannabis conference in Utah https://seekingalpha.com/news/3389064-sativa-growth-to-co-host-first-cannabis-conference-in-utah?source=tweet\" data-url=\"https://seekingalpha.com/news/3389064-sativa-growth-to-co-host-first-cannabis-conference-in-utah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389063\" data-ts=\"1536590958\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RGSE\" target=\"_blank\">RGSE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389063-real-goods-solarminus-7-on-secondary-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Real Goods Solar -7% on secondary stock offering</a></h4><ul>     <li>Real Goods Solar (<a href='https://seekingalpha.com/symbol/RGSE' title='RGS Energy, Inc.'>RGSE</a> <font color='red'>-7.2%</font>) sinks after submitting an <a href=\"https://www.sec.gov/Archives/edgar/data/1425565/000114420418048566/tv502474_s3.htm\" target=\"_blank\">SEC filing</a> for a secondary stock offering of more than 54.6M shares.</li>     <li>RGSE will receive no the proceeds from the proposed sale by the selling shareholders.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389063\" data-linked=\"Real Goods Solar -7% on secondary stock offering\" data-tweet=\"$RGSE - Real Goods Solar -7% on secondary stock offering https://seekingalpha.com/news/3389063-real-goods-solarminus-7-on-secondary-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3389063-real-goods-solarminus-7-on-secondary-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389061\" data-ts=\"1536590561\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389061-bofaml-apples-iphone-prices-increase-20-under-trumps-plan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BofAML: Apple&#39;s iPhone prices could increase 20% under Trump&#39;s plan</a></h4><ul><li>        Bank of America Merrill Lynch <a href=\"https://www.cnbc.com/2018/09/10/bank-of-america-says-iphone-prices-may-rise-if-apple-assembles-its-phones-in-us.html\" target=\"_blank\">estimates</a> that Apple&rsquo;s (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) iPhone prices would increase up to 20% if the company assembles in the US like President Donald Trump wants. &nbsp;</li><li>        On Saturday, President Trump tweeted that Apple should manufacturer its products domestically to avoid his proposed Chinese tariffs.</li><li>                  The tweet came a day after the release of Apple&rsquo;s letter to U.S. trade representative Robert Lighthizer, which said the newly proposed tariffs would affect the Apple Watch, AirPods, Mac mini, and Apple Pencil.    </li><li>               BofAML analyst Wamsi Mohan&rsquo;s estimated price increase would pertain to Apple moving 100% of final assembly to the US, which would require a higher price to offset the labor costs.&nbsp;</li><li>               Mohan finds it more likely Apple would move 10% of iPhone assembly to the US, which would raise the iPhone ASP by 8%.&nbsp;</li><li>               Mohan reiterates his Buy rating and $250 price target on Apple, a 13% upside to Friday&rsquo;s close.&nbsp;</li><li>               Apple shares are&nbsp;<font color='red'>down 1.9%</font>&nbsp;to $217.16.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3388913-trump-says-apple-shift-production-u-s-avoid-china-tariffs\" target=\"_blank\">Trump says Apple should shift production to U.S. to avoid China tariffs</a> (Sept. 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3389061\" data-linked=\"BofAML: Apple&#39;s iPhone prices could increase 20% under Trump&#39;s plan\" data-tweet=\"$AAPL - BofAML: Apple&#39;s iPhone prices could increase 20% under Trump&#39;s plan https://seekingalpha.com/news/3389061-bofaml-apples-iphone-prices-increase-20-under-trumps-plan?source=tweet\" data-url=\"https://seekingalpha.com/news/3389061-bofaml-apples-iphone-prices-increase-20-under-trumps-plan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>86&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389059\" data-ts=\"1536590130\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MLCO\" target=\"_blank\">MLCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389059-nomura-recommends-buying-macau-weakness\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nomura recommends buying into Macau weakness</a></h4><ul> <li>Nomura attributes the carnage in the Macau sector to comments made by several junket operators such as SunCity on flattish VIP volume expectations for 2019.</li> <li>Analyst Harry Curtis notes that the large sell-off in many Macau names doesn't correspond to the only 2% to 2.5% downward adjustment that needs to be made to 2019 estimates to account for the forecast. \"We believe this decline is too severe, especially since Macau&rsquo;s growth rate is one of the strongest globally, and growth in table supply is limited to 3% annually,\" writes Curtis.</li> <li>Curtis recommends buying Melco Resorts &amp; Entertainment (<a href='https://seekingalpha.com/symbol/MLCO' title='Melco Resorts & Entertainment Limited ADR'>MLCO</a> <font color='red'>-2.8%</font>), Wynn Resorts (<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a> <font color='green'>+2.5%</font>) and MGM Resorts (<a href='https://seekingalpha.com/symbol/MGM' title='MGM Resorts International'>MGM</a> <font color='green'>+0.9%</font>) on the weakness. He sees rising free cash flow yields as the company's project capex winds down. He also notes the lower valuations of the trio in comparison to Las Vegas Sands (<a href='https://seekingalpha.com/symbol/LVS' title='Las Vegas Sands Corp.'>LVS</a> <font color='green'>+0.8%</font>).</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3389059\" data-linked=\"Nomura recommends buying into Macau weakness\" data-tweet=\"$MLCO $MLCO $WYNN - Nomura recommends buying into Macau weakness https://seekingalpha.com/news/3389059-nomura-recommends-buying-macau-weakness?source=tweet\" data-url=\"https://seekingalpha.com/news/3389059-nomura-recommends-buying-macau-weakness\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389058\" data-ts=\"1536589819\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACOR\" target=\"_blank\">ACOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389058-acorda-down-15-on-adverse-patent-ruling\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acorda down 15% on adverse patent ruling</a></h4><ul><li>Acorda Therapeutics (<a href='https://seekingalpha.com/symbol/ACOR' title='Acorda Therapeutics, Inc.'>ACOR</a> <font color='red'>-15.4%</font>) slumps on almost 25% higher volume in response to losing its appeal to revive certain Ampyra (dalfampridine) patents.</li><li><a href=\"https://seekingalpha.com/pr/17265299-u-s-court-appeals-federal-circuit-upholds-district-court-s-decision-invalidate-ampyra\" target=\"_blank\">In 2-1 vote</a>, the U.S. Court of Appeals for the Federal Circuit upheld the district court's ruling invalidating four U.S. patents covering Ampyra.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3378250-acorda-working-ampyra-patent-infringement-cases\" target=\"_blank\">Acorda working through Ampyra patent infringement cases</a> (Aug. 3)</li></ul><div class=\"tiny-share-widget\" data-id=\"3389058\" data-linked=\"Acorda down 15% on adverse patent ruling\" data-tweet=\"$ACOR - Acorda down 15% on adverse patent ruling https://seekingalpha.com/news/3389058-acorda-down-15-on-adverse-patent-ruling?source=tweet\" data-url=\"https://seekingalpha.com/news/3389058-acorda-down-15-on-adverse-patent-ruling\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389054\" data-ts=\"1536589482\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DCTH\" target=\"_blank\">DCTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389054-delcath-systems-up-21-following-2_5m-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Delcath Systems up 21% following $2.5M capital raise</a></h4><ul><li>Ultra-thinly traded nano cap Delcath Systems (<a href='https://seekingalpha.com/symbol/DCTH' title='Delcath Systems, Inc.'>OTC:DCTH</a> <font color='green'>+21.4%</font>) is up on double normal volume, albeit on turnover of only 19K shares, in reaction to its $2.5M capital raise.</li><li>In an <a href=\"https://www.sec.gov/Archives/edgar/data/872912/000119312518269251/d619285d8k.htm\" target=\"_blank\">8-K filed after the close </a>on Friday, September 7, the company disclosed that it raised gross proceeds of $2.5M via the sale of ~$3.3M face value of its 8% Senior Secured Convertible Promissory Notes, ~2M warrants and ~23.8M pre-funded warrants to Discover Growth Fund, LLC.</li><li>It also dropped the conversion price to $1.75 on its notes issued on June 4, 2018 and July 20, 2018 and agreed that the first $2.5M raised from its rights offering and 50% of its future financings will be allocated to satisfying this debt. The number of warrants under the July 20 deal has been raised to ~22.2M from ~13M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389054\" data-linked=\"Delcath Systems up 21% following $2.5M capital raise\" data-tweet=\"$DCTH - Delcath Systems up 21% following $2.5M capital raise https://seekingalpha.com/news/3389054-delcath-systems-up-21-following-2_5m-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3389054-delcath-systems-up-21-following-2_5m-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389055\" data-ts=\"1536589481\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TAPM\" target=\"_blank\">TAPM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389055-tapinator-repurchases-and-cancels-all-of-preferred-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tapinator repurchases and cancels all of its preferred shares</a></h4><ul>     <li>Tapinator (<a href='https://seekingalpha.com/symbol/TAPM' title='Tapinator, Inc.'>OTCQB:TAPM</a> <font color='green'>+22.1%</font>) has repurchased 1,354 shares of the Company's Series B Convertible Preferred Stock for a purchase price of $270.83/share.</li>     <li>Post transaction, the Company will have no Preferred Stock outstanding in any class.</li>     <li>Ilya Nikolayev, CEO of Tapinator, also commented, \"This transaction is a testament to the strong conviction we currently maintain for our core mobile gaming and applications business.   By repurchasing a significant quantity of our own shares, we hope to send a strong signal to the market that the recent price decline is contrary to our belief in the fundamental health and outlook for Tapinator.\"</li>     <li><a href=\"https://seekingalpha.com/pr/17264815-tapinator-repurchases-cancels-preferred-shares\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3389055\" data-linked=\"Tapinator repurchases and cancels all of its preferred shares\" data-tweet=\"$TAPM - Tapinator repurchases and cancels all of its preferred shares https://seekingalpha.com/news/3389055-tapinator-repurchases-and-cancels-all-of-preferred-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3389055-tapinator-repurchases-and-cancels-all-of-preferred-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389052\" data-ts=\"1536589088\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COE\" target=\"_blank\">COE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389052-china-online-education-up-2_4-post-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China Online Education up 2.4% post Q2 results</a></h4><ul><li>China Online Education (<a href='https://seekingalpha.com/symbol/COE' title='China Online Education Group &#40;51Talk&#41;'>COE</a> <font color='green'>+2.4%</font>)&nbsp;<a href=\"https://seekingalpha.com/pr/17264497-china-online-education-group-announces-second-quarter-2018-results\" target=\"_blank\">reports Q2</a>&nbsp;revenue growth of 46.9% Y/Y to RMB 281.7M, the increase was primarily attributed to an increase in the number of active students and, to a lesser extent, an increase in the average revenue per active student.</li><li>The number of active students in Q2 were 195.5K, an increase of 28.8% Y/Y.</li><li>Gross billings were RMB420M (+18.3% Y/Y); percentage of gross billings contributed by K-12 students was 83.5%.</li><li>K-12 mass-market one-on-one offering of 278 (+50.6% Y/Y); K-12 American Academy one-on-one offering 29.2 (-57.2% Y/Y) &amp; K-12 small class offering were 43.5.</li><li>Gross margin&nbsp;<font color='green'>increased 280 bps</font>&nbsp;to 65.7%.</li><li>Total operating expenses were RMB261.7M (+1.3% Y/Y) the increase was mainly the result of increases in S&amp;M, partially offset by decreases of product development, and G&amp;A expenses.</li><li>Total cash, equivalents, time deposits and short-term investments of RMB601.5M.</li><li>The Company had deferred revenues of RMB1,390.6M.</li><li><strong>Q3 Outlook:</strong>&nbsp;Net revenues of RMB 295-300M, which would represent an increase of ~24.9%-27.1% Y/Y; Gross billings of RMB 410-420M, which would represent an increase of ~16%-18.8% Y/Y.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3388919-china-online-education-reports-q2-results\" target=\"_blank\">China Online Education reports Q2 results</a> (Sept. 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3389052\" data-linked=\"China Online Education up 2.4% post Q2 results\" data-tweet=\"$COE - China Online Education up 2.4% post Q2 results https://seekingalpha.com/news/3389052-china-online-education-up-2_4-post-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3389052-china-online-education-up-2_4-post-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389049\" data-ts=\"1536588757\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTD\" target=\"_blank\">FTD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389049-ftd-droops-to-all-time-low\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FTD droops to all-time low</a></h4><ul> <li>Shares of FTD Companies (NASDAQ:<a href='https://seekingalpha.com/symbol/FTD' title='FTD Companies, Inc.'>FTD</a>) <font color='red'>peel off 11%</font> after the company loses its place in the S&amp;P SmallCap 600 Index.</li> <li>FTD fell to an all-time low of $3.03 earlier in the session.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3388886-weight-watchers-plus-4_3-percent-move-midcap-400\" target=\"_blank\">Weight Watchers +4.3% on move to MidCap 400</a> (Sept. 7)</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3389049\" data-linked=\"FTD droops to all-time low\" data-tweet=\"$FTD - FTD droops to all-time low https://seekingalpha.com/news/3389049-ftd-droops-to-all-time-low?source=tweet\" data-url=\"https://seekingalpha.com/news/3389049-ftd-droops-to-all-time-low\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389047\" data-ts=\"1536588440\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PGLC\" target=\"_blank\">PGLC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389047-pershing-gold-down-9-on-sec-charges-to-key-investors\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pershing Gold down 9% on SEC charges to key investors</a></h4><ul><li>Thinly traded nano cap Pershing Gold (<a href='https://seekingalpha.com/symbol/PGLC' title='Pershing Gold Corporation'>PGLC</a> <font color='red'>-8.9%</font>) is down again, adding to Friday's&nbsp;<font color='red'>18%</font>&nbsp;plunge on the news that investors Phillip Frost and Barry Honig have been <a href=\"https://seekingalpha.com/news/3388849-pershing-gold-15-percent-sec-charges-investors-frost-honig\" target=\"_blank\">charged </a>with securities fraud by the SEC.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389047\" data-linked=\"Pershing Gold down 9% on SEC charges to key investors\" data-tweet=\"$PGLC - Pershing Gold down 9% on SEC charges to key investors https://seekingalpha.com/news/3389047-pershing-gold-down-9-on-sec-charges-to-key-investors?source=tweet\" data-url=\"https://seekingalpha.com/news/3389047-pershing-gold-down-9-on-sec-charges-to-key-investors\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389044\" data-ts=\"1536588046\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OBLN\" target=\"_blank\">OBLN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389044-obalon-up-12-strategy-update-commences\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Obalon up 12% as strategy update commences</a></h4><ul><li>Thinly traded nano cap Obalon Therapeutics (<a href='https://seekingalpha.com/symbol/OBLN' title='Obalon Therapeutics'>OBLN</a> <font color='green'>+12.4%</font>) is up in early trade. Its previously announced strategy update webcast is starting momentarily.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3387141-key-events-next-week-healthcare\" target=\"_blank\">Key events next week - healthcare</a> (Sept. 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3389044\" data-linked=\"Obalon up 12% as strategy update commences\" data-tweet=\"$OBLN - Obalon up 12% as strategy update commences https://seekingalpha.com/news/3389044-obalon-up-12-strategy-update-commences?source=tweet\" data-url=\"https://seekingalpha.com/news/3389044-obalon-up-12-strategy-update-commences\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389040\" data-ts=\"1536587450\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAIC\" target=\"_blank\">SAIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389040-science-applications-international-down-7_9-post-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Science Applications International down 7.9% post Q2 results</a></h4><ul><li>Science Applications International (<a href='https://seekingalpha.com/symbol/SAIC' title='Science Applications International Corporation'>SAIC</a> <font color='red'>-7.9%</font>) <u><a href=\"https://seekingalpha.com/filing/4164972\" target=\"_blank\">reports Q2</a></u> revenue growth of 3.7% Y/Y to $1.12B.</li><li>Q2 Overall margins: Operating&nbsp;<font color='green'>increased 110 bps</font>&nbsp;to 6.6%; Adj. operating&nbsp;<font color='green'>increased 90 bps</font>&nbsp;to 6.6%; EBITDA&nbsp;<font color='green'>increased to 100 bps</font>&nbsp;to 7.5% &amp; Adj. EBITDA&nbsp;<font color='green'>increased 80 bps</font>&nbsp;to 7.5%.</li><li>Deployed&nbsp;$22M of capital, consisting of&nbsp;$13M in cash dividends and a&nbsp;$9M term loan repayment.</li><li>No plan share repurchases were made as SAIC evaluated alternative capital deployment opportunities including the pending acquisition of Engility.</li><li>Net bookings for the quarter were ~$&nbsp;1.5B.</li><li>Book-to-bill ratio was&nbsp;1.4.</li><li>The company estimated backlog of signed business orders of ~$10.5B of which&nbsp;$2.1B was funded.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3388964-science-applications-beats-0_14-beats-revenue\" target=\"_blank\">Science Applications beats by $0.14, beats on revenue</a> (Sept. 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3389040\" data-linked=\"Science Applications International down 7.9% post Q2 results\" data-tweet=\"$SAIC - Science Applications International down 7.9% post Q2 results https://seekingalpha.com/news/3389040-science-applications-international-down-7_9-post-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3389040-science-applications-international-down-7_9-post-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389031\" data-ts=\"1536586595\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FPRX\" target=\"_blank\">FPRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389031-five-prime-launches-late-stage-study-of-bemarituzumab-chemo-in-gastric-cancer-gej-shares-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Five Prime launches late-stage study of bemarituzumab + chemo in gastric cancer or GEJ; shares up 2%</a></h4><ul><li>Five Prime Therapeutics (<a href='https://seekingalpha.com/symbol/FPRX' title='Five Prime Therapeutics, Inc.'>FPRX</a> <font color='green'>+1.6%</font>) has <a href=\"https://seekingalpha.com/pr/17265017-five-prime-therapeutics-completes-phase-1-safety-lead-initiates-phase-3-global-registrational\" target=\"_blank\">completed </a>the Phase 1 portion of its Phase 1/3 clinical trial evaluating FPA144 (bemarituzumab) plus chemotherapy in treatment-naive patients with advanced gastric cancer or gastroesophageal junction &#40;GEJ&#41; cancer. The Phase 3 portion has now been initiated.</li><li>The primary endpoint of the study, called <a href=\"https://clinicaltrials.gov/ct2/show/NCT03343301?intr=fpa+144&amp;lead=five+prime+therapeutics&amp;rank=1\" target=\"_blank\">FIGHT</a>, will be overall survival. Secondary endpoints include progression-free survival and objective response rate.</li><li>Bemarituzumab is a humanized monoclonal antibody that binds to a protein called FGFR2b, an oncogene overexpressed in up to 35% of gastric cancer cases.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389031\" data-linked=\"Five Prime launches late-stage study of bemarituzumab + chemo in gastric cancer or GEJ; shares up 2%\" data-tweet=\"$FPRX - Five Prime launches late-stage study of bemarituzumab + chemo in gastric cancer or GEJ; shares up 2% https://seekingalpha.com/news/3389031-five-prime-launches-late-stage-study-of-bemarituzumab-chemo-in-gastric-cancer-gej-shares-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3389031-five-prime-launches-late-stage-study-of-bemarituzumab-chemo-in-gastric-cancer-gej-shares-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389027\" data-ts=\"1536586088\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HOV\" target=\"_blank\">HOV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389027-hovnanian-beats-0_06-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hovnanian beats by $0.06, misses on revenue</a></h4><ul><li>Hovnanian (NYSE:<a href='https://seekingalpha.com/symbol/HOV' title='Hovnanian Enterprises, Inc.'>HOV</a>): Q3 GAAP EPS of -$0.01 <span style=\"color:green\">beats by $0.06</span>.</li><li>Revenue of $456.71M (-22.9% Y/Y) <font color='red'>misses by $47.59M</font>.</li><li>Shares <font color='green'>+5.2%</font> PM.</li><li><a href='https://seekingalpha.com/pr/17265049-hovnanian-enterprises-reports-fiscal-2018-third-quarter-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3389027\" data-linked=\"Hovnanian beats by $0.06, misses on revenue\" data-tweet=\"$HOV - Hovnanian beats by $0.06, misses on revenue https://seekingalpha.com/news/3389027-hovnanian-beats-0_06-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3389027-hovnanian-beats-0_06-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389026\" data-ts=\"1536585986\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FRED\" target=\"_blank\">FRED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389026-premarket-gainers-of-9-05-09-10-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (09/10/2018)</a></h4><ul><li><a href='https://seekingalpha.com/symbol/FRED' title='Fred&#39;s, Inc.'>FRED</a> <font color='green'>+64%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3388994-walgreens-acquires-pharmacy-files-freds\" target=\"_blank\">acquiring</a>&nbsp;pharmacy files from Fred.</li><li><a href='https://seekingalpha.com/symbol/ECYT' title='Endocyte, Inc.'>ECYT</a> <font color='green'>+15%</font>&nbsp;as FDA <a href=\"https://seekingalpha.com/news/3388991-fda-accepts-endocytes-rpfs-alternative-primary-endpoint-vision-trial-addition-os\" target=\"_blank\">accepts</a> Endocyte's rPFS as an alternative primary endpoint of the VISION trial in addition to OS.</li><li><a href='https://seekingalpha.com/symbol/FTEK' title='Fuel Tech, Inc.'>FTEK</a> <font color='green'>+12%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3389011-fuel-tech-awarded-air-pollution-control-orders-totaling-15_8m-shares-13-percent-premarket\" target=\"_blank\">being awarded</a> air pollution control orders totaling $15.8M.</li><li><a href='https://seekingalpha.com/symbol/DRAD' title='Digirad Corporation'>DRAD</a> <font color='green'>+12%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17264506-digirad-corporation-announces-conversion-holding-company-structure\" target=\"_blank\">conversion</a> to holding company structure.</li><li><a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a> <font color='green'>+6%</font>&nbsp;as <a href=\"https://seekingalpha.com/news/3388904-riot-blockchain-ceo-exits-named-sec-suit\" target=\"_blank\">CEO exits</a> after being named in SEC suit.</li><li><a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a> <font color='green'>+6%</font>&nbsp;on Supreme Cannabis sign cannabis supply <a href=\"https://seekingalpha.com/pr/17264594-supreme-cannabis-signs-cannabis-supply-agreement-tilray\" target=\"_blank\">agreement</a>.</li><li><a href='https://seekingalpha.com/symbol/TRVN' title='Trevena, Inc.'>TRVN</a> <font color='green'>+6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389026\" data-linked=\"Premarket Gainers as of 9:05 am (09/10/2018)\" data-tweet=\"$FRED $FRED $ECYT - Premarket Gainers as of 9:05 am (09/10/2018) https://seekingalpha.com/news/3389026-premarket-gainers-of-9-05-09-10-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3389026-premarket-gainers-of-9-05-09-10-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389023\" data-ts=\"1536585612\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBS\" target=\"_blank\">CBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389023-cbs-pay-moonves-120m-depends-on-investigation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CBS could pay Moonves $120M, depends on investigation</a></h4><ul><li>        CBS (NYSE:<a href='https://seekingalpha.com/symbol/CBS' title='CBS Corporation'>CBS</a>) says it <a href=\"https://www.reuters.com/article/cbs-moonves/cbs-to-pay-120-mln-to-moonves-pending-probe-outcome-idUSL3N1VW4D0?feedType=RSS&amp;feedName=companyNews&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+reuters%2FcompanyNews+%28News+%2F+US+%2F+Company+News%29\" target=\"_blank\">will pay $120M</a> to former CEO Leslie Moonves if an internal investigation fails to provide grounds for his dismissal.</li><li>               Moonves resigned yesterday as a new wave of sexual assault and harassment allegations.&nbsp;</li><li>               CBS says that, under the settlement, Moonves could end up with zilch if the investigation goes the other direction. &nbsp;&nbsp;</li><li>               CBS shares are&nbsp;<font color='green'>up 1.7%</font>&nbsp;premarket to $57. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3388907-update-cbs-moonves-following-additional-reports-sexual-misconduct\" target=\"_blank\">Update: CBS' Moonves Out Following Additional Reports Of Sexual Misconduct</a> (Sept. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3389023\" data-linked=\"CBS could pay Moonves $120M, depends on investigation\" data-tweet=\"$CBS $VIAC - CBS could pay Moonves $120M, depends on investigation https://seekingalpha.com/news/3389023-cbs-pay-moonves-120m-depends-on-investigation?source=tweet\" data-url=\"https://seekingalpha.com/news/3389023-cbs-pay-moonves-120m-depends-on-investigation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389017\" data-ts=\"1536584920\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNXP\" target=\"_blank\">TNXP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389017-premarket-losers-of-9-05-9-10-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (9/10/2018)</a></h4><ul><li><a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a> <font color='red'>-16%</font>.</li><li><a href='https://seekingalpha.com/symbol/FOLD' title='Amicus Therapeutics, Inc.'>FOLD</a>&nbsp;<font color='red'>-8%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3388965-amicus-therapeutics-announces-regulatory-clinical-updates-gaa-pompe-disease\" target=\"_blank\">announcing</a> regulatory and clinical updates for AT-GAA in pompe disease.</li><li><a href='https://seekingalpha.com/symbol/GEMP' title='Gemphire Therapeutics'>GEMP</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3389017\" data-linked=\"Premarket Losers as of 9:05 am (9/10/2018)\" data-tweet=\"$TNXP $TNXP $FOLD - Premarket Losers as of 9:05 am (9/10/2018) https://seekingalpha.com/news/3389017-premarket-losers-of-9-05-9-10-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3389017-premarket-losers-of-9-05-9-10-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389012\" data-ts=\"1536584410\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CWH\" target=\"_blank\">CWH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389012-barrons-bounce-for-camping-world\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barron&#39;s bounce for Camping World</a></h4><ul> <li>Camping Word Holdings (NYSE:<a href='https://seekingalpha.com/symbol/CWH' title='Camping World Holdings'>CWH</a>) is <font color='green'>up 1.66%</font> in premarket trading after being <a href=\"https://www.barrons.com/articles/looking-for-bargains-in-the-recent-rv-wreck-1536364800\" target=\"_blank\">called out</a> in Barron's as a top pick in the RV sector.</li> <li>\"Camping World looks cheap compared with the industry&rsquo;s manufacturers. It could be the best way to play an eventual rebound in the stocks,\" writes Nicholas Jasinski.</li><li>Jasinski notes that the RV sector is seeing increased demand from millennial campers.</li> <li>Shares of Camping World are down 54% YTD.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3389012\" data-linked=\"Barron&#39;s bounce for Camping World\" data-tweet=\"$CWH - Barron&#39;s bounce for Camping World https://seekingalpha.com/news/3389012-barrons-bounce-for-camping-world?source=tweet\" data-url=\"https://seekingalpha.com/news/3389012-barrons-bounce-for-camping-world\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389006\" data-ts=\"1536583970\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLDR\" target=\"_blank\">CLDR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389006-clouderaplus-3-target-boost-platform-launch\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cloudera +3% target boost, platform launch</a></h4><ul><li>        Citi maintains a Buy rating on Cloudera (NYSE:<a href='https://seekingalpha.com/symbol/CLDR' title='Cloudera, Inc.'>CLDR</a>) and raises the price target from $21 to $24, a 37% upside to Friday&rsquo;s close.</li><li>               Analyst Tyler Radke cites Q2 results and expects more improvements in the future. &nbsp;&nbsp;</li><li>               Source: StreetAccount.&nbsp;</li><li>               In other news, Cloudera <a href=\"https://seekingalpha.com/pr/17264611-cloudera-delivers-powerful-machine-learning-analytics-platform-cloudera-enterprise-6\" target=\"_blank\">launches</a> its Cloudera Enterprise 6.0 platform for data warehousing and machine learning and the hybrid cloud innovations Cloudera Altus.&nbsp;</li><li>               Cloudera shares are&nbsp;<font color='green'>up 3.1%</font>&nbsp;premarket to $18.10.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3388145-cloudera-plus-10-percent-q2-subscription-strength-upside-guidance\" target=\"_blank\">Cloudera +10% on Q2 subscription strength, upside guidance</a> (Sept. 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3389006\" data-linked=\"Cloudera +3% target boost, platform launch\" data-tweet=\"$CLDR - Cloudera +3% target boost, platform launch https://seekingalpha.com/news/3389006-clouderaplus-3-target-boost-platform-launch?source=tweet\" data-url=\"https://seekingalpha.com/news/3389006-clouderaplus-3-target-boost-platform-launch\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389001\" data-ts=\"1536583655\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STZ\" target=\"_blank\">STZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389001-suntrust-cools-on-constellation-brands\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SunTrust cools on Constellation Brands</a></h4><ul> <li>SunTrust downgrades Constellation Brands (NYSE:<a href='https://seekingalpha.com/symbol/STZ' title='Constellation Brands, Inc.'>STZ</a>) to Hold from Buy due to concerns on the $4B investment in Canopy Growth.</li> <li>Analyst William Chappell questions the projection of long-term operating margins of 30% for the Canopy business if larger consumer goods companies enter the market.</li> <li>SunTrust lowers its price target on Constellation to $220 from $260 with the investment story now changed.</li> <li>Shares of Constellation are <font color='red'>down 2.38%</font> in premarket trading to $206.68.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3389001\" data-linked=\"SunTrust cools on Constellation Brands\" data-tweet=\"$STZ - SunTrust cools on Constellation Brands https://seekingalpha.com/news/3389001-suntrust-cools-on-constellation-brands?source=tweet\" data-url=\"https://seekingalpha.com/news/3389001-suntrust-cools-on-constellation-brands\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388994\" data-ts=\"1536582793\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WBA\" target=\"_blank\">WBA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388994-walgreens-acquires-pharmacy-files-from-freds\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Walgreens acquires pharmacy files from Fred&#39;s</a></h4><ul> <li>Walgreens Boots Alliance (NASDAQ:<a href='https://seekingalpha.com/symbol/WBA' title='Walgreens Boots Alliance, Inc.'>WBA</a>) announces that it acquired pharmacy files from 185 Fred's (NASDAQ:<a href='https://seekingalpha.com/symbol/FRED' title='Fred&#39;s, Inc.'>FRED</a>) pharmacies for $165M.</li><li>The transaction is part of a previously announced plan by Fred&rsquo;s to       unlock shareholder value by monetizing non-core assets through strategic       transactions.</li>          <li>Fred&rsquo;s says it will continue to operate its retail stores at most       of these locations after the pharmacies close.</li><li>Once the transaction is       complete, Fred&rsquo;s will continue to operate approximately 162 pharmacies       across nearly 600 stores.</li><li>On the Walgreens side, the deal gives the company increased exposure in the Southeastern U.S.</li><li>The companies expect the       file transfers to begin in Q4.</li><li>FRED  <font color='green'>+31.5%</font> premarket to  $2.15.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17264776-walgreens-purchase-pharmacy-files-185-fred-s-pharmacies-across-southeastern-u-s\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3388994\" data-linked=\"Walgreens acquires pharmacy files from Fred&#39;s\" data-tweet=\"$WBA $WBA $FRED - Walgreens acquires pharmacy files from Fred&#39;s https://seekingalpha.com/news/3388994-walgreens-acquires-pharmacy-files-from-freds?source=tweet\" data-url=\"https://seekingalpha.com/news/3388994-walgreens-acquires-pharmacy-files-from-freds\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388991\" data-ts=\"1536582563\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ECYT\" target=\"_blank\">ECYT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388991-fda-accepts-endocytes-rpfs-alternative-primary-endpoint-of-vision-trial-in-addition-to-os\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA accepts Endocyte&#39;s rPFS as an alternative primary endpoint of the VISION trial in addition to OS</a></h4><ul> <li>Endocyte (NASDAQ:<a href='https://seekingalpha.com/symbol/ECYT' title='Endocyte, Inc.'>ECYT</a>) <a href=\"https://seekingalpha.com/pr/17264693-endocyte-announces-fda-acceptance-radiographic-progression-free-survival-rpfs-alternative\" target=\"_blank\">announces</a> that following a meeting with the FDA, it was determined that radiographic Progression Free Survival ((rPFS)) is an appropriate efficacy endpoint in the ongoing phase 3 VISION trial to support the submission of a NDA for full FDA approval of Lu-PSMA-617 for the treatment of metastatic castration-resistant prostate cancer (mCRPC).</li><li>The alternative primary endpoints of the trial agreed to by the&nbsp;FDA&nbsp;are rPFSand overall survival &#40;OS&#41;. A positive assessment on either is sufficient for full approval.</li><li>A positive assessment on either is sufficient for full approval. In the case of the rPFS assessment, a corresponding assessment of OS will be made to ensure no detriment in OS has occurred. &nbsp;Secondary endpoints include response evaluation criteria in solid tumors response and time to first symptomatic skeletal event.</li>            <li>The Company also retained the final, fully powered OS analysis, which is expected to occur near the end of 2020.&nbsp;&nbsp;rPFS analysis for full approval is expected to occur before the end of 2019.</li>      <li>The rPFS analysis will include approximately 450 rPFS events.</li><li>Shares are up&nbsp;<font color='green'>7%</font>&nbsp;premarket.</li>            </ul><div class=\"tiny-share-widget\" data-id=\"3388991\" data-linked=\"FDA accepts Endocyte&#39;s rPFS as an alternative primary endpoint of the VISION trial in addition to OS\" data-tweet=\"$ECYT - FDA accepts Endocyte&#39;s rPFS as an alternative primary endpoint of the VISION trial in addition to OS https://seekingalpha.com/news/3388991-fda-accepts-endocytes-rpfs-alternative-primary-endpoint-of-vision-trial-in-addition-to-os?source=tweet\" data-url=\"https://seekingalpha.com/news/3388991-fda-accepts-endocytes-rpfs-alternative-primary-endpoint-of-vision-trial-in-addition-to-os\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388990\" data-ts=\"1536582327\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSNC\" target=\"_blank\">SSNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388990-analyst-upgrades-ss-and-c-on-attractive-entry-point\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analyst upgrades SS&amp;C on attractive entry point</a></h4><ul><li>        Deutsche Bank <a href=\"https://www.streetinsider.com/Analyst+Comments/Deutsche+Bank+Upgrades+SS%26C+Technologies+Holdings%2C+Inc.+%28SSNC%29+to+Buy/14590552.html\" target=\"_blank\">upgrades</a> SS&amp;C Tech (NASDAQ:<a href='https://seekingalpha.com/symbol/SSNC' title='SS&C Technologies Holdings, Inc.'>SSNC</a>) from Hold to Buy and raises the price target from $57 to $72, a 35% upside to Friday&rsquo;s close.</li><li>               Analyst Ashish Sabadra says the &ldquo;pullback on Intralinks acquisition concerns has created an attractive entry point given the strategic rationale as well as favorable financials.&rdquo;&nbsp;</li><li>               The analyst sees minimal integration risk and expects SSNC to report solid beats and raises over the next few quarters.&nbsp;</li><li>                  SS&amp;C shares are&nbsp;<font color='green'>up 1.2%</font>&nbsp;premarket to $53.97. </li><li>Previously: <a href=\"https://seekingalpha.com/news/3388819-ss-and-c-minus-2_9-percent-analyst-downgrade-intralinks-buy\" target=\"_blank\">SS&amp;C -2.9% on analyst downgrade for Intralinks buy</a> (Sept. 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3388990\" data-linked=\"Analyst upgrades SS&amp;C on attractive entry point\" data-tweet=\"$SSNC - Analyst upgrades SS&amp;C on attractive entry point https://seekingalpha.com/news/3388990-analyst-upgrades-ss-and-c-on-attractive-entry-point?source=tweet\" data-url=\"https://seekingalpha.com/news/3388990-analyst-upgrades-ss-and-c-on-attractive-entry-point\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388989\" data-ts=\"1536582168\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OSTK\" target=\"_blank\">OSTK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388989-overstock-complus-6-after-maxim-points-to-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Overstock.com +6% after Maxim points to upside</a></h4><ul> <li>Overstock.com (NASDAQ:<a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a>) breaks higher after Maxim initiates coverage with a Buy rating on its expectation that profitability from the retail segment is around the corner. Maxim forecasts a turn by Overstock.com to free cash flow positive by 2020.</li> <li>The research firm's price target of $75 on Overstock.com reps 188% upside potential from Friday's closing price.</li> <li>Shares of OTSK are <font color='green'>up 5.77%</font> premarket to $27.50.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3388989\" data-linked=\"Overstock.com +6% after Maxim points to upside\" data-tweet=\"$OSTK - Overstock.com +6% after Maxim points to upside https://seekingalpha.com/news/3388989-overstock-complus-6-after-maxim-points-to-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3388989-overstock-complus-6-after-maxim-points-to-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388982\" data-ts=\"1536581142\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYCC\" target=\"_blank\">CYCC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388982-cyclacel-pharmaceuticals-initiates-phase-1b-2-trial-of-sapacitabine-olaparib-in-brca-mutant\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cyclacel Pharmaceuticals initiates Phase 1b/2 trial of sapacitabine with olaparib in BRCA mutant breast cancer</a></h4><ul> <li>Cyclacel Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CYCC' title='Cyclacel Pharmaceuticals, Inc.'>CYCC</a>) <a href=\"https://seekingalpha.com/pr/17264620-cyclacel-pharmaceuticals-announces-initiation-phase-1b-2-clinical-trial-sapacitabine-olaparib\" target=\"_blank\">initiates</a> a Phase 1b/2 investigator-sponsored clinical trial to evaluate the safety and effectiveness of sapacitabine in combination with olaparib in patients with BRCA mutant breast cancer.</li><li>The trial will be conducted at the Dana-Farber Cancer Institute with collaborators Cyclacel and AstraZeneca providing sapacitabine investigational drug and the approved PARP-inhibitor olaparib (Lynparza), respectively.</li>         <li>The study will enroll ~64 patients. The primary endpoints are to determine maximum tolerated dose, recommended Phase 2 dose and objective response rate. Progression-free survival will be assessed as a secondary endpoint.</li><li>Shares are up&nbsp;<font color='green'>4%</font>&nbsp;premarket.</li>        </ul><div class=\"tiny-share-widget\" data-id=\"3388982\" data-linked=\"Cyclacel Pharmaceuticals initiates Phase 1b/2 trial of sapacitabine with olaparib in BRCA mutant breast cancer\" data-tweet=\"$CYCC - Cyclacel Pharmaceuticals initiates Phase 1b/2 trial of sapacitabine with olaparib in BRCA mutant breast cancer https://seekingalpha.com/news/3388982-cyclacel-pharmaceuticals-initiates-phase-1b-2-trial-of-sapacitabine-olaparib-in-brca-mutant?source=tweet\" data-url=\"https://seekingalpha.com/news/3388982-cyclacel-pharmaceuticals-initiates-phase-1b-2-trial-of-sapacitabine-olaparib-in-brca-mutant\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388976\" data-ts=\"1536580672\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZS\" target=\"_blank\">ZS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388976-zscalerminus-1_3-on-analyst-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zscaler -1.3% on analyst downgrade</a></h4><ul><li>        BTIG <a href=\"https://www.streetinsider.com/Analyst+Comments/BTIG+Downgrades+Zscaler+%28ZS%29+to+Neutral/14590375.html\" target=\"_blank\">downgrades</a> Zscaler (NASDAQ:<a href='https://seekingalpha.com/symbol/ZS' title='Zscaler'>ZS</a>) from Buy to Neutral citing valuation, sending shares&nbsp;<font color='red'>down 1.3%&nbsp;</font>premarket to $45.45. &nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3388976\" data-linked=\"Zscaler -1.3% on analyst downgrade\" data-tweet=\"$ZS - Zscaler -1.3% on analyst downgrade https://seekingalpha.com/news/3388976-zscalerminus-1_3-on-analyst-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3388976-zscalerminus-1_3-on-analyst-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388975\" data-ts=\"1536580633\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALDR\" target=\"_blank\">ALDR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388975-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>Alder BioPharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ALDR' title='Alder Biopharmaceuticals Inc.'>ALDR</a>) initiated with Underweight rating and $19 (5% upside) price target at Morgan Stanley.</li><li>MyoKardia (NASDAQ:<a href='https://seekingalpha.com/symbol/MYOK' title='MyoKardia'>MYOK</a>) initiated with Overweight rating and $72 (18% upside) price target at Morgan Stanley.</li><li>Exelixis (NASDAQ:<a href='https://seekingalpha.com/symbol/EXEL' title='Exelixis, Inc.'>EXEL</a>) initiated with Underweight rating and $19 (2% upside) price target at Morgan Stanley. Shares down&nbsp;<font color='red'>1%</font>&nbsp;premarket.</li><li>Neurocrine Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/NBIX' title='Neurocrine Biosciences, Inc.'>NBIX</a>) initiated with Overweight rating and $145 (24% upside) price target at Morgan Stanley.</li><li>Ultragenyx (NASDAQ:<a href='https://seekingalpha.com/symbol/RARE' title='Ultragenyx Pharmaceutical Inc.'>RARE</a>) initiated with Equal Weight rating and $92 (9% upside) price target at Morgan Stanley.</li><li>G1 Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/GTHX' title='G1 Therapeutics'>GTHX</a>) resumed with Buy rating and $80 (31% upside) price target at BTIG Research.</li><li>Voyager Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/VYGR' title='Voyager Therapeutics'>VYGR</a>) resumed with Buy rating and $32 (66% upside) price target at BTIG. Downgraded to Equal Weight at Morgan Stanley.</li><li>Acceleron Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/XLRN' title='Acceleron Pharma Inc.'>XLRN</a>) resumed with Equal Weight rating and $55 (8% upside) price target at Morgan Stanley.</li><li>Cytokinetics (NASDAQ:<a href='https://seekingalpha.com/symbol/CYTK' title='Cytokinetics, Incorporated'>CYTK</a>) resumed with Equal Weight rating and $10 (27% upside) price target at Morgan Stanley.</li><li>MacroGenics (NASDAQ:<a href='https://seekingalpha.com/symbol/MGNX' title='MacroGenics, Inc.'>MGNX</a>) resumed with Buy rating and $30 (39% upside) price target at BTIG.</li><li>Xencor (NASDAQ:<a href='https://seekingalpha.com/symbol/XNCR' title='Xencor, Inc.'>XNCR</a>) resumed with Buy rating and $56 (43% upside) price target at BTIG.</li><li>Inogen (NASDAQ:<a href='https://seekingalpha.com/symbol/INGN' title='Inogen, Inc'>INGN</a>) downgraded to Buy from Strong Buy with a $296 (12% upside) price target at Needham citing slower expected growth and increasing competition, although not significant enough to warrant a Hold rating. Shares up a fraction premarket.</li><li>Anthem (NYSE:<a href='https://seekingalpha.com/symbol/ANTM' title='Anthem, Inc.'>ANTM</a>) downgraded to Neutral at Citigroup.</li><li>UnitedHealth Group (NYSE:<a href='https://seekingalpha.com/symbol/UNH' title='UnitedHealth Group Inc.'>UNH</a>) downgraded to Neutral at Citigroup. Shares down&nbsp;<font color='red'>1%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3388975\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$ALDR $ALDR $MYOK - Premarket analyst action - healthcare https://seekingalpha.com/news/3388975-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3388975-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388973\" data-ts=\"1536580237\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKAM\" target=\"_blank\">AKAM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388973-da-davidson-upgrades-akamai-to-25-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DA Davidson upgrades Akamai to 25% upside</a></h4><ul><li>        DA Davidson upgrades Akamai Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/AKAM' title='Akamai Technologies, Inc.'>AKAM</a>) from Neutral to Buy and raises the target from $82 to $93, a 25% upside to Friday&rsquo;s close.</li><li>               The firm cites a meeting with management to discuss Q2 results and the company&rsquo;s industry position going into 2019.&nbsp;</li><li>               DA Davidson thinks Akamai is successfully executing its transition to security vendor thanks to its strong position in the content delivery market.&nbsp;</li><li>               Source: Briefing.com.&nbsp;</li><li>               Akamai shares are&nbsp;<font color='green'>up 1.4%</font>&nbsp;premarket to $75.53.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3388973\" data-linked=\"DA Davidson upgrades Akamai to 25% upside\" data-tweet=\"$AKAM - DA Davidson upgrades Akamai to 25% upside https://seekingalpha.com/news/3388973-da-davidson-upgrades-akamai-to-25-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3388973-da-davidson-upgrades-akamai-to-25-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388957\" data-ts=\"1536578086\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388957-analysts-dig-in-on-tesla\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts dig in on Tesla</a></h4><ul> <li>Baird maintains a bullish view on Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) on the upside potential it sees with the Model 3 rollout. Analyst Ben Kallo calls the extended share price fall a \"buying opportunity\" for investors as he names the EV automaker a \"fresh pick\" and reiterates a price target of $411 on the EV automaker.</li> <li>Bernstein is more cautious due to the lack of clarity on Model 3 margins, keeping a Market Perform rating and price target of $325 in place. The firm does see more risk for bears on the Tesla upside than bulls on the downside.</li> <li>Needham keeps an Underperform rating on Tesla on concerns over margins and the high rate of management turnover.</li><li>Wall Street scorecard on Tesla: 10 Buy-equivalent ratings, 11 Hold-equivalent ratings, 11 Sell-equivalent ratings (per Bloomberg data).</li> <li>Tesla is <font color='green'>up 2.95%</font> on premarket avolume of ~35K shares.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3388957\" data-linked=\"Analysts dig in on Tesla\" data-tweet=\"$TSLA - Analysts dig in on Tesla https://seekingalpha.com/news/3388957-analysts-dig-in-on-tesla?source=tweet\" data-url=\"https://seekingalpha.com/news/3388957-analysts-dig-in-on-tesla\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>244&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388952\" data-ts=\"1536577653\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPK\" target=\"_blank\">OPK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388952-opko-health-takes-issue-sec-complaint\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OPKO Health takes issue with SEC complaint</a></h4><ul><li>In a <a href=\"https://seekingalpha.com/pr/17264367-opko-comments-sec-complaint\" target=\"_blank\">statement</a>, OPKO Health (NYSEMKT:<a href='https://seekingalpha.com/symbol/OPK' title='OPKO Health, Inc.'>OPK</a>) says if the SEC had followed its own procedures and notified the company and Dr. Phillip Frost of its intent to file a complaint, both would have provided the necessary information that would have \"answered a number of the SEC's apparent questions,\" avoiding the filing of the lawsuit, adding \"OPKO and&nbsp;Dr. Frost&nbsp;have always prided themselves on adhering to the highest standards of financial disclosure, and they are confident that once a proper investigation is completed and the facts of the case have been fully disclosed, the matter will be resolved favorably for them.&rdquo;</li><li>The company notes that the complaint does not accuse the company of misbehavior in its business practices, financial statements or financial practices.</li><li>Shares were down&nbsp;<font color='red'>18%</font>&nbsp;on Friday in reaction to the news.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3388837-sec-charges-frost-honig-stock-promotion-schemes-opko-18-percent\" target=\"_blank\">SEC charges Frost and Honig with stock promotion schemes; OPKO down 18%</a> (Sept. 7)</li><li><strong>Update</strong>: On September 14, the company <a href=\"https://seekingalpha.com/pr/17270630-opko-confirms-resumption-common-stock-trading-nasdaq\" target=\"_blank\">confirmed </a>the resumption of trading, halted on September 7, and stated the it will \"vigorously defend itself\" against the SEC charges.</li></ul><div class=\"tiny-share-widget\" data-id=\"3388952\" data-linked=\"OPKO Health takes issue with SEC complaint\" data-tweet=\"$OPK - OPKO Health takes issue with SEC complaint https://seekingalpha.com/news/3388952-opko-health-takes-issue-sec-complaint?source=tweet\" data-url=\"https://seekingalpha.com/news/3388952-opko-health-takes-issue-sec-complaint\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>57&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3388933\" data-ts=\"1536575088\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRNE\" target=\"_blank\">SRNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3388933-sorrento-therapeutics-raises-140m-in-royalty-based-financing-to-support-commercialization-of\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sorrento Therapeutics raises $140M in royalty-based financing to support the commercialization of ZTlido pain medication</a></h4><ul><li>Sorrento Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a>) <a href=\"https://seekingalpha.com/pr/17264476-sorrento-therapeutics-subsidiary-scilex-raises-140-million-non-dilutive-royalty-based\" target=\"_blank\">announces</a> that its majority-owned subsidiary, Scilex Pharmaceuticals, closed a debt financing with leading global institutional investors for gross proceeds to Scilex of $140M.</li><li>Net proceeds will be used for working capital and general corporate purposes in respect of commercialization of ZTlido (lidocaine topical system) 1.8%.</li>        <li>On September 7, Scilex issued and sold senior secured notes due 2026 in an aggregate principal amount of $224M for an aggregate purchase price of $140M. The holders of the Notes will be entitled to receive quarterly payments of principal of the Notes equal to a percentage of the net sales of ZTlido.</li><li>ZTlido is indicated for the relief of pain associated with post-herpetic neuralgia, also referred to as post-shingles pain.</li><li>Additionally, Scilex has recruited a team of 11 regional business directors and has partnered with Syneos Health (formerly InVentiv Health) to support a sales force of over 100 representatives.</li><li><strong>Update</strong>: Shares are up&nbsp;<font color='green'>4%</font>&nbsp;premarket on light volume.</li>            </ul><div class=\"tiny-share-widget\" data-id=\"3388933\" data-linked=\"Sorrento Therapeutics raises $140M in royalty-based financing to support the commercialization of ZTlido pain medication\" data-tweet=\"$SRNE - Sorrento Therapeutics raises $140M in royalty-based financing to support the commercialization of ZTlido pain medication https://seekingalpha.com/news/3388933-sorrento-therapeutics-raises-140m-in-royalty-based-financing-to-support-commercialization-of?source=tweet\" data-url=\"https://seekingalpha.com/news/3388933-sorrento-therapeutics-raises-140m-in-royalty-based-financing-to-support-commercialization-of\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":69,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}